[{"internal_id": 85588838, "Award ID": "UH3HL140144", "Award Amount": 2068406.28, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-30", "CFDA Number": "93.837", "Description": "IMPACT OF LOW FLOW NOCTURNAL OXYGEN THERAPY ON HOSPITAL READMISSION/MORTALITYIN PATIENTS WITH HEART FAILURE AND CENTRAL SLEEP APNEAL (LOFT-HF)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18478032-6084-4969-2e94-0f121ba8b8b2-C", "generated_internal_id": "ASST_NON_UH3HL140144_7529"}, {"internal_id": 50111379, "Award ID": "UH3HL123610", "Award Amount": 3886105.32, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-01-23", "CFDA Number": "93.837", "Description": "THERAPEUTIC TARGETING OF CAROTID BODY CHEMOREFLEX FOR SLEEP DISORDERED BREATHING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4bd68be-2bd0-4a42-0d20-0ad92720d93c-C", "generated_internal_id": "ASST_NON_UH3HL123610_7529"}, {"internal_id": 67579386, "Award ID": "UG3HL140144", "Award Amount": 108610.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-07-31", "CFDA Number": "93.233", "Description": "IMPACT OF LOW FLOW NOCTURNAL OXYGEN THERAPY ON HOSPITAL READMISSION/MORTALITYIN PATIENTS WITH HEART FAILURE AND CENTRAL SLEEP APNEAL (LOFT-HF)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18478032-6084-4969-2e94-0f121ba8b8b2-C", "generated_internal_id": "ASST_NON_UG3HL140144_7529"}, {"internal_id": 67580277, "Award ID": "U24HL140412", "Award Amount": 2116589.25, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-07-27", "CFDA Number": "93.837", "Description": "IMPACT OF LOW FLOW NOCTURNAL OXYGEN THERAPY ON HOSPITAL ADMISSIONS AND MORTALITY IN PATIENTS WITH HEART FAILURE AND CENTRAL SLEEP APNEA - DCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_U24HL140412_7529"}, {"internal_id": 50098741, "Award ID": "U1CRH03712", "Award Amount": 7484490.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2008-08-29", "CFDA Number": "93.155", "Description": "RURAL HEALTH RESEARCH GRANT PROGRAM COOPERATIVE AGREEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8a022699-f7be-356a-f01a-3aa6f76016ef-C", "generated_internal_id": "ASST_NON_U1CRH03712_7526"}, {"internal_id": 50097335, "Award ID": "U16RH03702", "Award Amount": 19947620.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2007-07-31", "CFDA Number": "93.547", "Description": "RURAL HEALTH BEST PRACTICES AND COMMUNITY DEVELOPMENT COOPERATIVE AGREEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "676622ec-bfc8-de80-706f-a121e172b4a0-C", "generated_internal_id": "ASST_NON_U16RH03702_7526"}, {"internal_id": 86316599, "Award ID": "U01HL150835", "Award Amount": 4631654.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.279", "Description": "EVALUATING THE ROLE OF THE OREXIN SYSTEM IN CIRCADIAN RHYTHMS OF SLEEP AND STRESS IN PERSONS ON MEDICATION-ASSISTED TREATMENTS FOR OPIOID USE DISORDER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_U01HL150835_7529"}, {"internal_id": 86316539, "Award ID": "U01HL150596", "Award Amount": 4920190.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-09-26", "CFDA Number": "93.279", "Description": "THE COLLABORATION LINKING OPIOID USE DISORDER AND SLEEP (\"CLOUDS\") STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1882697f-2df0-529a-ed60-116702c184a7-C", "generated_internal_id": "ASST_NON_U01HL150596_7529"}, {"internal_id": 86317925, "Award ID": "U01HL150568", "Award Amount": 5298536.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.279", "Description": "EFFECTS OF EXPERIMENTAL SLEEP DISRUPTION AND FRAGMENTATION ON CEREBRAL MU-OPIOID RECEPTOR FUNCTION, MU-OPIOID RECEPTOR AGONIST ANALGESIA, AND ABUSE LIABILITY.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_U01HL150568_7529"}, {"internal_id": 86318859, "Award ID": "U01HL150551", "Award Amount": 4021723.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.279", "Description": "DUAL-OREXIN ANTAGONISM AS A MECHANISM FOR IMPROVING SLEEP AND DRUG ABSTINENCE IN OPIOID USE DISORDER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "57f1d8a4-43a0-9952-a047-67afb28d0b55-C", "generated_internal_id": "ASST_NON_U01HL150551_7529"}, {"internal_id": 50095143, "Award ID": "U01HL126088", "Award Amount": 2814166.73, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-11", "CFDA Number": "93.837", "Description": "ICOMPARE - DCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_U01HL126088_7529"}, {"internal_id": 50095138, "Award ID": "U01HL125388", "Award Amount": 5134121.86, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-10", "CFDA Number": "93.837", "Description": "ICOMPARE-CCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_U01HL125388_7529"}, {"internal_id": 50095137, "Award ID": "U01HL125307", "Award Amount": 5185505.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-04", "CFDA Number": "93.837", "Description": "IMPACT OF TREATMENT OF MILD SLEEP-DISORDERED BREATHING ON CHILDREN'S HEALTH-DCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_U01HL125307_7529"}, {"internal_id": 50095136, "Award ID": "U01HL125295", "Award Amount": 7924751.82, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-04", "CFDA Number": "93.837", "Description": "IMPACT OF TREATMENT OF MILD SLEEP-DISORDERED BREATHING ON CHILDREN'S HEALTH-CCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_U01HL125295_7529"}, {"internal_id": 50095041, "Award ID": "U01HL111691", "Award Amount": 1913508.25, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2012-09-12", "CFDA Number": "93.837", "Description": "MULTI-CENTER TRIAL OF LIMITING PGY2&3 RESIDENT WORK HOURS ON PATIENT SAFETY-DCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7e9ab48c-ed7b-1b28-d315-5376f2046c8e-C", "generated_internal_id": "ASST_NON_U01HL111691_7529"}, {"internal_id": 50095036, "Award ID": "U01HL111478", "Award Amount": 8406051.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2012-09-12", "CFDA Number": "93.233", "Description": "MULTI-CENTER TRIAL OF LIMITING PGY2&3 RESIDENT WORK HOURS ON PATIENT SAFETY-CCC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_U01HL111478_7529"}, {"internal_id": 95484893, "Award ID": "T32HL149646", "Award Amount": 869952.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-02-19", "CFDA Number": "93.837", "Description": "TRANSDISCIPLINARY TRAINING IN SLEEP AND CIRCADIAN RHYTHMS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7d586cfa-95f6-0e31-3589-fbd59b788eda-C", "generated_internal_id": "ASST_NON_T32HL149646_7529"}, {"internal_id": 68565011, "Award ID": "T32HL139438", "Award Amount": 1237200.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-03-30", "CFDA Number": "93.837", "Description": "THE CELLULAR AND SYSTEMS BIOLOGY OF SLEEP AND CIRCADIAN RHYTHMS TRAINING PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3533688b-b8fb-c3f8-76e6-68ad9ad84b99-C", "generated_internal_id": "ASST_NON_T32HL139438_7529"}, {"internal_id": 50032391, "Award ID": "T32HL110952", "Award Amount": 5040222.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-07-12", "CFDA Number": "93.837", "Description": "MULTI-INSTITUTIONAL TRAINING IN GENETIC/GENOMIC APPROACHES TO SLEEP DISORDERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_T32HL110952_7529"}, {"internal_id": 50032326, "Award ID": "T32HL082610", "Award Amount": 4371098.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-06-29", "CFDA Number": "93.837", "Description": "TRANSLATIONAL RESEARCH TRAINING IN SLEEP MEDICINE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_T32HL082610_7529"}, {"internal_id": 50032274, "Award ID": "T32HL007953", "Award Amount": 6016632.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-08-10", "CFDA Number": "93.837", "Description": "TRAINING IN SLEEP AND SLEEP DISORDERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_T32HL007953_7529"}, {"internal_id": 50032261, "Award ID": "T32HL007913", "Award Amount": 1967771.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-07-06", "CFDA Number": "93.233", "Description": "SLEEP MEDICINE NEUROBIOLOGY AND EPIDEMIOLOGY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "59649428-1ebf-ef93-ea43-2491b55b3188-C", "generated_internal_id": "ASST_NON_T32HL007913_7529"}, {"internal_id": 50032259, "Award ID": "T32HL007909", "Award Amount": 5734430.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2008-09-01", "CFDA Number": "93.837", "Description": "TRAINING GRANT IN SLEEP RESEARCH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b0be845a-babe-8a5d-2f4b-002e5eff7fcd-C", "generated_internal_id": "ASST_NON_T32HL007909_7529"}, {"internal_id": 50032257, "Award ID": "T32HL007901", "Award Amount": 12029308.76, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-07-16", "CFDA Number": "93.837", "Description": "TRAINING IN SLEEP, CIRCADIAN AND RESPIRATORY NEUROBIOLOGY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_T32HL007901_7529"}, {"internal_id": 50032219, "Award ID": "T32HL007713", "Award Amount": 8780615.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-06-30", "CFDA Number": "93.837", "Description": "TRAINING PROGRAM IN SLEEP AND RESPIRATORY NEUROBIOLOGY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_T32HL007713_7529"}, {"internal_id": 85588760, "Award ID": "R61HL151254", "Award Amount": 465336.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-13", "CFDA Number": "93.310", "Description": "MEDICATIONS FOR OBSTRUCTIVE SLEEP APNEA TO IMPROVE COGNITION IN CHILDREN WITH DOWN SYNDROME (MOSAIC DS)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4f121097-1173-861e-ba01-a877858acd3d-C", "generated_internal_id": "ASST_NON_R61HL151254_7529"}, {"internal_id": 86316944, "Award ID": "R61HL151253", "Award Amount": 863337.77, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-20", "CFDA Number": "93.310", "Description": "POSITIVE AIRWAY PRESSURE FOR THE TREATMENT OF THE OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN WITH DOWN SYNDROME", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_R61HL151253_7529"}, {"internal_id": 85589829, "Award ID": "R56HL148430", "Award Amount": 515655.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-18", "CFDA Number": "93.837", "Description": "PERSONALIZING OBSTRUCTIVE SLEEP APNEA MANAGEMENT: ASSOCIATING SYMPTOM SUBTYPE TO OBJECTIVE SLEEP TRAITS AND PHYSIOLOGICAL BIOMARKERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "030ff4e1-5b82-35d0-a78c-551a23bb4ba1-C", "generated_internal_id": "ASST_NON_R56HL148430_7529"}, {"internal_id": 69724182, "Award ID": "R56HL142757", "Award Amount": 292558.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-19", "CFDA Number": "93.233", "Description": "MILD INTERMITTENT HYPOXIA AND CPAP: A MULTI-PRONGED APPROACH TO TREAT SLEEP APNEA IN INTACT AND SPINAL CORD INJURED HUMANS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "57f1d8a4-43a0-9952-a047-67afb28d0b55-C", "generated_internal_id": "ASST_NON_R56HL142757_7529"}, {"internal_id": 49826842, "Award ID": "R56HL131010", "Award Amount": 646533.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-14", "CFDA Number": "93.233", "Description": "NEUROCHEMICAL ASSESSMENT OF SLEEP APNEA USING ACCELERATED MR SPECTROSCOPIC IMAGING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3231cda5-201a-6da0-de9e-e9810a848983-C", "generated_internal_id": "ASST_NON_R56HL131010_7529"}, {"internal_id": 110862405, "Award ID": "R43HL154870", "Award Amount": 252113.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-21", "CFDA Number": "93.837", "Description": "SLEEPFLEXTM HEAD AND NECK EXERCISE PROGRAM FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "72778ed4-1177-1b78-5c6d-f97829730b5c-C", "generated_internal_id": "ASST_NON_R43HL154870_7529"}, {"internal_id": 98486689, "Award ID": "R43HL152948", "Award Amount": 244863.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-01", "CFDA Number": "93.837", "Description": "DELIVERY SYSTEM TO INCREASE ADHERENCE TO MYOFUNCTIONAL THERAPY PROTOCOL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1758639d-4017-866a-de2d-d4bd40182d19-C", "generated_internal_id": "ASST_NON_R43HL152948_7529"}, {"internal_id": 110862009, "Award ID": "R43HL151549", "Award Amount": 224672.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-24", "CFDA Number": "93.837", "Description": "LOW BURDEN WEARABLE SENSOR SYSTEM FOR DIAGNOSING OBSTRUCTIVE SLEEP APNEA IN OLDER ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2424a8b1-fc04-3ba6-2a64-63c43a9a4120-C", "generated_internal_id": "ASST_NON_R43HL151549_7529"}, {"internal_id": 68565594, "Award ID": "R43HL142315", "Award Amount": 399429.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-17", "CFDA Number": "93.837", "Description": "DISCOVERING GIRK CHANNEL DIRECT ACTIVATOR AS A NOVEL CHRONIC INSOMNIA THERAPEUTIC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "65935cb6-ac04-1978-fa08-490d8f77e730-C", "generated_internal_id": "ASST_NON_R43HL142315_7529"}, {"internal_id": 110233988, "Award ID": "R41HL150933", "Award Amount": 299743.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-05", "CFDA Number": "93.837", "Description": "NON-INVASIVE OROPHARYNX APPLIANCE TO MAINTAIN AIRWAY PATENCY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "772342e8-655e-3dbb-bb63-3d30f5b9edf7-R", "generated_internal_id": "ASST_NON_R41HL150933_7529"}, {"internal_id": 68566019, "Award ID": "R41HL142489", "Award Amount": 223940.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-05-23", "CFDA Number": "93.837", "Description": "TECHNOLOGY FOR NON-INVASIVE HIGH-THROUGHPUT BREATH TRACKING IN RODENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "88a17d33-77e8-ada2-2bd5-7117f4abc880-C", "generated_internal_id": "ASST_NON_R41HL142489_7529"}, {"internal_id": 49811610, "Award ID": "R35HL135818", "Award Amount": 7246745.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-12-28", "CFDA Number": "93.837", "Description": "PHENOTYPIC AND MOLECULAR SIGNATURES FOR SLEEP APNEA AND RELATED MORBIDITIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R35HL135818_7529"}, {"internal_id": 49810573, "Award ID": "R34HL135360", "Award Amount": 656951.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-04-10", "CFDA Number": "93.233", "Description": "POSTURAL THERAPY REDUCES SLEEP DISORDERED BREATHING AND CARDIOMETABOLIC STRESS AT ALTITUDE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_R34HL135360_7529"}, {"internal_id": 49810569, "Award ID": "R34HL135073", "Award Amount": 716650.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-21", "CFDA Number": "93.837", "Description": "A SLEEP HYGIENE INTERVENTION TO IMPROVE SLEEP QUALITY IN URBAN, LATINO MIDDLE SCHOOL CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f21f887-ca03-f1f2-6e30-1c1498f78b9e-C", "generated_internal_id": "ASST_NON_R34HL135073_7529"}, {"internal_id": 49807046, "Award ID": "R25HL120874", "Award Amount": 1533997.75, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-08-14", "CFDA Number": "93.837", "Description": "USE OF TELEMEDICINE TO PROMOTE SLEEP MEDICINE EDUCATION IN HEALTHCARE TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R25HL120874_7529"}, {"internal_id": 49807043, "Award ID": "R25HL116378", "Award Amount": 1046636.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-09-06", "CFDA Number": "93.233", "Description": "TAILORED SLEEP HEALTH EDUCATION: A COMMUNITY-ENGAGED APPROACH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c07787b9-15d4-d1eb-4f0c-2e0b30320bfb-C", "generated_internal_id": "ASST_NON_R25HL116378_7529"}, {"internal_id": 49807042, "Award ID": "R25HL116372", "Award Amount": 976588.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-08-25", "CFDA Number": "93.233", "Description": "SIESTA (SLEEP FOR INPATIENTS: EDUCATING STAFF TO ACT)  - RESUBMISSION 01", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4bd68be-2bd0-4a42-0d20-0ad92720d93c-C", "generated_internal_id": "ASST_NON_R25HL116372_7529"}, {"internal_id": 49805789, "Award ID": "R24HL114473", "Award Amount": 7441475.9, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-09-05", "CFDA Number": "93.837", "Description": "NATIONAL SLEEP RESEARCH RESOURCE (NSRR)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R24HL114473_7529"}, {"internal_id": 110464849, "Award ID": "R21HL150502", "Award Amount": 260831.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-08", "CFDA Number": "93.837", "Description": "CARDIOVASCULAR IMPLICATIONS OF SLEEP CHARACTERISTICS USING REAL-WORLD OBJECTIVE SLEEP DATA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8a022699-f7be-356a-f01a-3aa6f76016ef-C", "generated_internal_id": "ASST_NON_R21HL150502_7529"}, {"internal_id": 85588933, "Award ID": "R21HL145492", "Award Amount": 268500.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-03-27", "CFDA Number": "93.837", "Description": "SLEEP PHYSIOLOGY DYNAMICS: QUANTIFICATION, CHARACTERIZATION AND GENETIC DISSECTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R21HL145492_7529"}, {"internal_id": 83796564, "Award ID": "R21HL145425", "Award Amount": 268500.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-08-20", "CFDA Number": "93.233", "Description": "LEVERAGING CORRELATED TRAITS TO IDENTIFY GENETIC ASSOCIATIONS WITH SLEEP DISORDERED BREATHING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R21HL145425_7529"}, {"internal_id": 85589004, "Award ID": "R21HL145421", "Award Amount": 263295.61, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-08-29", "CFDA Number": "93.837", "Description": "ASSOCIATION OF HABITUAL SLEEP DURATION WITH PLASMA METABOLOMICS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7d586cfa-95f6-0e31-3589-fbd59b788eda-C", "generated_internal_id": "ASST_NON_R21HL145421_7529"}, {"internal_id": 49801189, "Award ID": "R21HL140447", "Award Amount": 231032.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.837", "Description": "SLEEP DISORDERED BREATHING AND CARDIOVASCULAR OUTCOME: NEW APPROACH AND SECONDARY ANALYSIS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "57f1d8a4-43a0-9952-a047-67afb28d0b55-C", "generated_internal_id": "ASST_NON_R21HL140447_7529"}, {"internal_id": 77190909, "Award ID": "R21HL140437", "Award Amount": 242677.27, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-02-01", "CFDA Number": "93.837", "Description": "SLEEP APNEA PHENOTYPES IN LATINOS (SLEPT)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dbae4064-c48c-5002-9fca-21d077e0f96b-C", "generated_internal_id": "ASST_NON_R21HL140437_7529"}, {"internal_id": 49801187, "Award ID": "R21HL140432", "Award Amount": 282521.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.233", "Description": "PULSE TRANSIT TIME AND BLOOD PRESSURE TRENDS DURING SLEEP AS NOVEL CARDIOVASCULAR MARKERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d604415e-e1c8-650f-1b30-5e424b71fcf7-C", "generated_internal_id": "ASST_NON_R21HL140432_7529"}, {"internal_id": 49801184, "Award ID": "R21HL140377", "Award Amount": 251864.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.837", "Description": "APNEA PATTERNS PREDICT HEART DISEASE AND MORTALITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_R21HL140377_7529"}, {"internal_id": 49801171, "Award ID": "R21HL138075", "Award Amount": 426250.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-04", "CFDA Number": "93.837", "Description": "CEREBRAL DIFFUSION: A NEW APPROACH TO SLEEP DISORDERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_R21HL138075_7529"}, {"internal_id": 49801166, "Award ID": "R21HL137874", "Award Amount": 420625.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-09", "CFDA Number": "93.233", "Description": "USE OF A VARIABLE DEAD SPACE REBREATHE DEVICE (SMART CO2) TO TREAT OBSTRUCTIVE AND CENTRAL SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f044e52c-101e-349e-69e4-aaa93e72f7ab-C", "generated_internal_id": "ASST_NON_R21HL137874_7529"}, {"internal_id": 67314961, "Award ID": "R21HL135516", "Award Amount": 284266.79, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-19", "CFDA Number": "93.837", "Description": "NOVEL COMPUTATIONAL APPROACHES FOR ASSESSING THE IMPACT OF CHRONIC INSUFFICIENT SLEEP ON BRAIN AND HEART DYNAMICS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18397352-674d-5e14-840f-49a4315ed3ca-C", "generated_internal_id": "ASST_NON_R21HL135516_7529"}, {"internal_id": 49801156, "Award ID": "R21HL135368", "Award Amount": 234000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-12-23", "CFDA Number": "93.233", "Description": "DISCOVERY AND CHARACTERIZATION OF CANDIDATE THERAPEUTICS FOR DRUG-INDUCED PULMONARY DISEASE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8ad38bc-2827-1399-cd46-c5204062852b-C", "generated_internal_id": "ASST_NON_R21HL135368_7529"}, {"internal_id": 49801019, "Award ID": "R21HL123666", "Award Amount": 225833.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-02", "CFDA Number": "93.233", "Description": "CPAP ADHERENCE AND POSTOPERATIVE DELIRIUM IN PATIENTS WITH OSA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e0af38c9-92a8-f2cb-a5b8-4b4f14f99689-C", "generated_internal_id": "ASST_NON_R21HL123666_7529"}, {"internal_id": 49800978, "Award ID": "R21HL121521", "Award Amount": 237000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-07-28", "CFDA Number": "93.233", "Description": "PREDICTIVE ADHERENCE MODELING (PAM) STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0c13d643-4334-38ed-1952-0db7e2ac5e56-C", "generated_internal_id": "ASST_NON_R21HL121521_7529"}, {"internal_id": 67313790, "Award ID": "R15HL140504", "Award Amount": 435782.56, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-13", "CFDA Number": "93.837", "Description": "SOCIAL DETERMINANTS OF SLEEP AND SLEEP DISPARITIES AMONG COLLEGE STUDENTS: THE INFLUENCE OF CHILDHOOD ADVERSITY, CONTEMPORANEOUS STRESS, AND PROXIMAL BEHAVIORAL MEDIATORS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dff5ea13-87ef-1d23-7ba0-fbf570ef2475-C", "generated_internal_id": "ASST_NON_R15HL140504_7529"}, {"internal_id": 110234021, "Award ID": "R03HL154284", "Award Amount": 179000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-04", "CFDA Number": "93.837", "Description": "IDENTIFYING CONTRIBUTIONS OF PULMONARY INFLAMMATION TO SLEEP-DISORDERED BREATHING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R03HL154284_7529"}, {"internal_id": 49774701, "Award ID": "R03HL140273", "Award Amount": 169500.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-13", "CFDA Number": "93.837", "Description": "DUAL-TRACER DUAL-BED HYBRID PET/MR IMAGING TO STUDY ATHEROSCLEROSIS PRE AND POST SLEEP APNEA TREATMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bace221f-a1f9-fa20-66e4-55984406cf48-C", "generated_internal_id": "ASST_NON_R03HL140273_7529"}, {"internal_id": 49774691, "Award ID": "R03HL138068", "Award Amount": 163113.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-22", "CFDA Number": "93.233", "Description": "PILOT STUDY OF BETA ADRENERGIC BLOCKADE TO PREVENT METABOLIC CONSEQUENCES OF SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_R03HL138068_7529"}, {"internal_id": 110464386, "Award ID": "R01HL153874", "Award Amount": 2026881.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-22", "CFDA Number": "93.837", "Description": "PHENOTYPING MECHANISTIC PATHWAYS FOR ADVERSE HEALTH OUTCOMES IN SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL153874_7529"}, {"internal_id": 97852946, "Award ID": "R01HL153612", "Award Amount": 2023100.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-05-21", "CFDA Number": "93.837", "Description": "HARNESSING TONGUE EXERCISE TO ENHANCE NEUROPLASTICITY AND PRESERVE UPPER AIRWAY FUNCTION IN A NOVEL MODEL OF HYPOGLOSSAL MOTOR NEURON DEGENERATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f261384c-3ac1-b344-de46-81708f87aa6a-C", "generated_internal_id": "ASST_NON_R01HL153612_7529"}, {"internal_id": 110463767, "Award ID": "R01HL153523", "Award Amount": 2135911.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-06-25", "CFDA Number": "93.837", "Description": "SEX DISPARITIES IN HYPOXIC SYMPATHOLYSIS AND IMPACT OF OBESITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f261384c-3ac1-b344-de46-81708f87aa6a-C", "generated_internal_id": "ASST_NON_R01HL153523_7529"}, {"internal_id": 110464274, "Award ID": "R01HL153320", "Award Amount": 1920000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-21", "CFDA Number": "93.837", "Description": "CARDIAC CIRCADIAN CLOCK AND DILATED CARDIOMYOPATHY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ddcd398f-5e59-e840-2368-a57b84efdc7d-C", "generated_internal_id": "ASST_NON_R01HL153320_7529"}, {"internal_id": 110463728, "Award ID": "R01HL153095", "Award Amount": 2793881.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-11", "CFDA Number": "93.837", "Description": "SEDENTARY BEHAVIOR, PHYSICAL ACTIVITY, SLEEP, AND CARDIOVASCULAR RISK IN PREGNANCY: THE PREGNANCY 24/7 COHORT STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0b441d38-e3c0-de89-ee08-69fc9e6ee58a-C", "generated_internal_id": "ASST_NON_R01HL153095_7529"}, {"internal_id": 110024992, "Award ID": "R01HL153042", "Award Amount": 2611611.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-26", "CFDA Number": "93.310", "Description": "CIRCADIAN CLOCK REGULATION OF MYOCARDIAL ION CHANNEL EXPRESSION AND FUNCTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_R01HL153042_7529"}, {"internal_id": 107114463, "Award ID": "R01HL152968", "Award Amount": 2453450.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-22", "CFDA Number": "93.837", "Description": "CIRCADIAN SIGNATURES IN CHRONIC LUNG DISEASE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e0af38c9-92a8-f2cb-a5b8-4b4f14f99689-C", "generated_internal_id": "ASST_NON_R01HL152968_7529"}, {"internal_id": 110464828, "Award ID": "R01HL152741", "Award Amount": 1537320.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-23", "CFDA Number": "93.837", "Description": "IDENTIFYING SLEEP TARGETS TO IMPROVE STROKE OUTCOMES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_R01HL152741_7529"}, {"internal_id": 110233784, "Award ID": "R01HL152454", "Award Amount": 1876165.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-04", "CFDA Number": "93.837", "Description": "INVESTIGATING SOCIO-ECOLOGICAL FACTORS IN PEDIATRIC SLEEP-RELATED HEALTH DISPARITIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_R01HL152454_7529"}, {"internal_id": 110232909, "Award ID": "R01HL152453", "Award Amount": 2475358.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-04", "CFDA Number": "93.837", "Description": "DORMIR: DETERMINANTS, OUTCOMES, RESPONSES AND MARKERS OF  INSUFFICIENT SLEEP IN RURAL-URBAN SETTINGS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dbae4064-c48c-5002-9fca-21d077e0f96b-C", "generated_internal_id": "ASST_NON_R01HL152453_7529"}, {"internal_id": 100874976, "Award ID": "R01HL152442", "Award Amount": 4932127.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-12", "CFDA Number": "93.837", "Description": "DETERMINANTS AND CARDIOVASCULAR CONSEQUENCES OF DISPARITIES IN SLEEP AND CIRCADIAN RHYTHMS BETWEEN BLACK AND WHITE ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_R01HL152442_7529"}, {"internal_id": 96204010, "Award ID": "R01HL151853", "Award Amount": 1530000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-04-03", "CFDA Number": "93.837", "Description": "NOVEL MECHANISM IN MICROBIOTA-BRAIN COMMUNICATION: THE ROLE OF THE HEPATOPORTAL REGION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "358711ab-dfdd-d789-9d79-6eaf11629381-C", "generated_internal_id": "ASST_NON_R01HL151853_7529"}, {"internal_id": 97002196, "Award ID": "R01HL151576", "Award Amount": 2942022.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-04-30", "CFDA Number": "93.837", "Description": "FLUORESCENT POLYSOMNOGRAPHY AND MCH NEUROGENETICS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0c13d643-4334-38ed-1952-0db7e2ac5e56-C", "generated_internal_id": "ASST_NON_R01HL151576_7529"}, {"internal_id": 107115186, "Award ID": "R01HL151512", "Award Amount": 2025221.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-27", "CFDA Number": "93.837", "Description": "ADOLESCENT CIRCADIAN PHASE SHIFTS: NOVEL TIME-OF-DAY TARGETS FOR BRIGHT LIGHT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3686b736-a954-3213-3e70-ff260e0ab96a-C", "generated_internal_id": "ASST_NON_R01HL151512_7529"}, {"internal_id": 97006757, "Award ID": "R01HL151389", "Award Amount": 3234832.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-04-23", "CFDA Number": "93.837", "Description": "NEUROGLIAL INTERACTIONS UNDERLYING THE GENERATION OF THE SIGH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e050350a-3939-bf65-9585-238517e3ab1f-C", "generated_internal_id": "ASST_NON_R01HL151389_7529"}, {"internal_id": 97014425, "Award ID": "R01HL151368", "Award Amount": 1686190.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-04-24", "CFDA Number": "93.837", "Description": "INVESTIGATING CIRCADIAN MECHANISMS OF CELLULAR RESILIENCE: RHYTHMIC CONDENSATES, DISORDER, AND STRESS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18397352-674d-5e14-840f-49a4315ed3ca-C", "generated_internal_id": "ASST_NON_R01HL151368_7529"}, {"internal_id": 86315992, "Award ID": "R01HL150836", "Award Amount": 2045252.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.279", "Description": "SLEEP, OPIATE WITHDRAWAL AND THE N/OFQ - NOP SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a43aff3e-a570-0cb9-f0e5-3f0b2cc7d6e9-C", "generated_internal_id": "ASST_NON_R01HL150836_7529"}, {"internal_id": 86318261, "Award ID": "R01HL150566", "Award Amount": 1638126.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.233", "Description": "AROUSAL CIRCUITRY AND OPIATE-ASSOCIATED MEMORIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0c13d643-4334-38ed-1952-0db7e2ac5e56-C", "generated_internal_id": "ASST_NON_R01HL150566_7529"}, {"internal_id": 86318332, "Award ID": "R01HL150523", "Award Amount": 1579710.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.279", "Description": "DECONSTRUCTING SLEEP DISRUPTION AS A MAJOR RISK FACTOR FOR RELAPSE IN OPIOID USE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fb8099df-df9c-1d96-f19c-f3a00b918c86-C", "generated_internal_id": "ASST_NON_R01HL150523_7529"}, {"internal_id": 86317306, "Award ID": "R01HL150432", "Award Amount": 1981041.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-21", "CFDA Number": "93.279", "Description": "CELL-TYPE SPECIFIC ROLE OF CIRCADIAN-DEPENDENT TRANSCRIPTION IN FENTANYL-INDUCED SYNAPTIC AND BEHAVIORAL PLASTICITY - SUPPLEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "68a12c06-0ac5-9595-eda2-d8647ffda5d0-C", "generated_internal_id": "ASST_NON_R01HL150432_7529"}, {"internal_id": 95181241, "Award ID": "R01HL149800", "Award Amount": 2649201.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-12-31", "CFDA Number": "93.837", "Description": "MICROGLIAL REGULATION OF INTERMITTENT HYPOXIA INDUCED PHRENIC MOTOR PLASTICITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_R01HL149800_7529"}, {"internal_id": 83115729, "Award ID": "R01HL149133", "Award Amount": 1989053.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-08-05", "CFDA Number": "93.837", "Description": "MEDULLARY CONTROL OF REM SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL149133_7529"}, {"internal_id": 110463922, "Award ID": "R01HL148704", "Award Amount": 3359311.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-24", "CFDA Number": "93.837", "Description": "PROTEOMIC AND TRANSCRIPTOMIC BIOMARKERS OF CIRCADIAN TIMING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0c13d643-4334-38ed-1952-0db7e2ac5e56-C", "generated_internal_id": "ASST_NON_R01HL148704_7529"}, {"internal_id": 85590473, "Award ID": "R01HL148574", "Award Amount": 3552609.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-13", "CFDA Number": "93.837", "Description": "ENVIRONMENTAL DETERMINANTS OF HUMAN SLEEP TIMING, DURATION AND CONTINUITY: STUDIES IN HUNTER GATHERERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3231cda5-201a-6da0-de9e-e9810a848983-C", "generated_internal_id": "ASST_NON_R01HL148574_7529"}, {"internal_id": 97853014, "Award ID": "R01HL148436", "Award Amount": 2608951.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-05-29", "CFDA Number": "93.837", "Description": "UNDERLYING MECHANISMS OF OBESITY-INDUCED OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_R01HL148436_7529"}, {"internal_id": 83797463, "Award ID": "R01HL148271", "Award Amount": 3541644.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-08-27", "CFDA Number": "93.837", "Description": "METS-SLEEP: SLEEP TIMING, GUT MICROBIOTA AND CARDIOMETABOLIC RISK ACROSS THE EPIDEMIOLOGIC TRANSITION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f2defd6b-38d0-6c66-8586-39b99ba99117-C", "generated_internal_id": "ASST_NON_R01HL148271_7529"}, {"internal_id": 110464180, "Award ID": "R01HL147915", "Award Amount": 2827669.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-03-17", "CFDA Number": "93.837", "Description": "IMPACT OF WELL-TIMED VS. MIS-TIMED SLEEP EXTENSION ON ADOLESCENTS? DIETARY INTAKE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8ad38bc-2827-1399-cd46-c5204062852b-C", "generated_internal_id": "ASST_NON_R01HL147915_7529"}, {"internal_id": 85588960, "Award ID": "R01HL147610", "Award Amount": 1528148.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-03-22", "CFDA Number": "93.837", "Description": "REDUCING SEDENTARY BEHAVIOR TO IMPROVE SLEEP: AN ANCILLARY STUDY TO THE RESET BP CLINICAL TRIAL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_R01HL147610_7529"}, {"internal_id": 85590741, "Award ID": "R01HL147328", "Award Amount": 4225825.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-07-23", "CFDA Number": "93.837", "Description": "INFLUENCE OF PRENATAL AIR POLLUTANT AND STRESS EXPOSURES ON SLEEP OUTCOMES IN URBAN PRESCHOOL-AGED CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bace221f-a1f9-fa20-66e4-55984406cf48-C", "generated_internal_id": "ASST_NON_R01HL147328_7529"}, {"internal_id": 96202003, "Award ID": "R01HL146772", "Award Amount": 2133343.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-03-20", "CFDA Number": "93.837", "Description": "ADOLESCENT CIRCADIAN MISALIGNMENT: MECHANISTIC STUDIES OF SLEEP AND LIGHT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3686b736-a954-3213-3e70-ff260e0ab96a-C", "generated_internal_id": "ASST_NON_R01HL146772_7529"}, {"internal_id": 85589981, "Award ID": "R01HL146709", "Award Amount": 2969246.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-08-28", "CFDA Number": "93.837", "Description": "IMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA FOR FAT METABOLISM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dbae4064-c48c-5002-9fca-21d077e0f96b-C", "generated_internal_id": "ASST_NON_R01HL146709_7529"}, {"internal_id": 85589251, "Award ID": "R01HL146697", "Award Amount": 3389990.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-05-29", "CFDA Number": "93.837", "Description": "A NOVEL PHARMACOLOGICAL THERAPY FOR OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL146697_7529"}, {"internal_id": 77190098, "Award ID": "R01HL146339", "Award Amount": 1340704.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-01-21", "CFDA Number": "93.837", "Description": "LEVERAGING NATIONAL SLEEP RESEARCH RESOURCE DATA FOR PERSONALIZED SLEEP PROFILING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL146339_7529"}, {"internal_id": 85588523, "Award ID": "R01HL146169", "Award Amount": 2569562.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-12-20", "CFDA Number": "93.837", "Description": "AD SUPPLEMENT TO HYPOTH NEURON ACTIVATION TO BLUNT MYOCAR REMODELING DURING CHRONIC SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ee8636d0-3f78-fbb3-4346-eb49aabbb2b3-C", "generated_internal_id": "ASST_NON_R01HL146169_7529"}, {"internal_id": 85589090, "Award ID": "R01HL146127", "Award Amount": 3857785.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-07-05", "CFDA Number": "93.837", "Description": "MECHANISMS OF PREDIABETIC STATES IN OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4bd68be-2bd0-4a42-0d20-0ad92720d93c-C", "generated_internal_id": "ASST_NON_R01HL146127_7529"}, {"internal_id": 85590223, "Award ID": "R01HL146059", "Award Amount": 3479967.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-04", "CFDA Number": "93.837", "Description": "IMPROVING OUTCOMES FOR PATIENTS WITH SDB AND INSUFFICIENT SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "57f1d8a4-43a0-9952-a047-67afb28d0b55-C", "generated_internal_id": "ASST_NON_R01HL146059_7529"}, {"internal_id": 85588769, "Award ID": "R01HL145470", "Award Amount": 2440153.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-03-22", "CFDA Number": "93.837", "Description": "RESPIRATORY AND GENOMIC CONTRIBUTIONS TO ADAPTIVE/MALADAPTIVE HYPOXIA RESPONSES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_R01HL145470_7529"}, {"internal_id": 68171305, "Award ID": "R01HL143790", "Award Amount": 3633018.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-08-24", "CFDA Number": "93.837", "Description": "ELUCIDATION OF GENETIC EFFECTS ON SLEEP AND CIRCADIAN TRAITS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL143790_7529"}, {"internal_id": 67313610, "Award ID": "R01HL143221", "Award Amount": 4218143.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-06", "CFDA Number": "93.837", "Description": "IMAGING THE ATHEROSCLEROSIS CASCADE IN SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bace221f-a1f9-fa20-66e4-55984406cf48-C", "generated_internal_id": "ASST_NON_R01HL143221_7529"}, {"internal_id": 98486092, "Award ID": "R01HL142981", "Award Amount": 3369095.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-06-26", "CFDA Number": "93.837", "Description": "METABOLOMICS OF OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL142981_7529"}, {"internal_id": 85588437, "Award ID": "R01HL142757", "Award Amount": 1632442.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-05-06", "CFDA Number": "93.837", "Description": "MILD INTERMITTENT HYPOXIA AND CPAP: A MULTI-PRONGED APPROACH TO TREAT SLEEP APNEA IN INTACT AND SPINAL CORD INJURED HUMANS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "57f1d8a4-43a0-9952-a047-67afb28d0b55-C", "generated_internal_id": "ASST_NON_R01HL142757_7529"}, {"internal_id": 77189165, "Award ID": "R01HL142752", "Award Amount": 3013062.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-02-01", "CFDA Number": "93.837", "Description": "FETAL REPROGRAMMING BY GESTATIONAL INTERMITTENT HYPOXIA IMPAIRS RESPIRATORY NEUROMOTOR CONTROL IN ADULT OFFSPRING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f044e52c-101e-349e-69e4-aaa93e72f7ab-C", "generated_internal_id": "ASST_NON_R01HL142752_7529"}, {"internal_id": 68567414, "Award ID": "R01HL142648", "Award Amount": 3820960.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-07", "CFDA Number": "93.837", "Description": "IMPACT OF CIRCADIAN MISALIGNMENT ON ENERGY BALANCE REGULATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f6a3877-304a-f4ec-9bd4-082c57aa1297-C", "generated_internal_id": "ASST_NON_R01HL142648_7529"}, {"internal_id": 67833394, "Award ID": "R01HL142605", "Award Amount": 2875650.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-08-17", "CFDA Number": "93.837", "Description": "OBESITY AND SLEEP APNEA IN PREGNANCY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3533688b-b8fb-c3f8-76e6-68ad9ad84b99-C", "generated_internal_id": "ASST_NON_R01HL142605_7529"}, {"internal_id": 68567384, "Award ID": "R01HL142118", "Award Amount": 2078217.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-20", "CFDA Number": "93.837", "Description": "IMPACT OF POOR SLEEP ON INFLAMMATION AND THE ADENOSINE SIGNALING PATHWAY IN HIV INFECTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_R01HL142118_7529"}, {"internal_id": 68567796, "Award ID": "R01HL142116", "Award Amount": 1857777.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-04-30", "CFDA Number": "93.837", "Description": "THE CONTRIBUTION OF SLEEP AND CIRCADIAN DISRUPTION TO KYNURENINE PATHWAY ACTIVATION AND CARDIOMETABOLIC RISK IN WOMEN WITH HIV", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1d7f817f-0c9f-3793-b912-1d49a6cdb0f4-C", "generated_internal_id": "ASST_NON_R01HL142116_7529"}, {"internal_id": 68566072, "Award ID": "R01HL142114", "Award Amount": 2004444.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-04-30", "CFDA Number": "93.837", "Description": "OBSTRUCTIVE SLEEP APNEA ENDOTYPES AND IMPACT ON PHENOTYPES OF PEOPLE LIVING WITH HIV", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_R01HL142114_7529"}, {"internal_id": 85589067, "Award ID": "R01HL142066", "Award Amount": 4697062.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-05-10", "CFDA Number": "93.837", "Description": "DETERMINANTS OF INSUFFICIENT SLEEP AMONG BLACKS AND EFFECTS ON DISPARITIES IN HEALTH OUTCOMES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dbae4064-c48c-5002-9fca-21d077e0f96b-C", "generated_internal_id": "ASST_NON_R01HL142066_7529"}, {"internal_id": 65578982, "Award ID": "R01HL142064", "Award Amount": 1633298.77, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-04-10", "CFDA Number": "93.837", "Description": "SLEEP AND CIRCADIAN MECHANISMS CONTRIBUTING TO DISPARITY IN PREVALENCE OF HYPERTENSION BETWEEN BLACK AND WHITE AMERICANS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_R01HL142064_7529"}, {"internal_id": 85589897, "Award ID": "R01HL142058", "Award Amount": 4000956.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-05-23", "CFDA Number": "93.837", "Description": "DISPARITIES IN SLEEP, ASTHMA, AND THE SLEEP CONTEXT IN URBAN CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f21f887-ca03-f1f2-6e30-1c1498f78b9e-C", "generated_internal_id": "ASST_NON_R01HL142058_7529"}, {"internal_id": 66994899, "Award ID": "R01HL142051", "Award Amount": 3477685.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-06-28", "CFDA Number": "93.837", "Description": "EXAMINING THE RECIPROCAL EFFECTS OF RACIAL DISCRIMINATION AND SLEEP ON CARDIOVASCULAR FUNCTIONING: AN EXPERIMENTAL APPROACH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bb8d1cd4-e0ae-6348-a07c-04df6a112768-C", "generated_internal_id": "ASST_NON_R01HL142051_7529"}, {"internal_id": 78598781, "Award ID": "R01HL141881", "Award Amount": 2667306.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-02-12", "CFDA Number": "93.837", "Description": "LEVERAGING A UNIQUE EXISTING COHORT TO ELUCIDATE THE LINK BETWEEN SLEEP AND CARDIO-METABOLIC DISEASE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_R01HL141881_7529"}, {"internal_id": 77190480, "Award ID": "R01HL141706", "Award Amount": 2204609.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-01-31", "CFDA Number": "93.837", "Description": "CIRCADIAN AND SLEEP PATHWAYS TO CARDIOMETABOLIC DISEASE RISK: ROLE OF NEUROBEHAVIORAL PROCESSES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "105d3de4-6fbf-6e42-7259-4c62267aa84f-C", "generated_internal_id": "ASST_NON_R01HL141706_7529"}, {"internal_id": 66199369, "Award ID": "R01HL141494", "Award Amount": 3599112.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-05-04", "CFDA Number": "93.837", "Description": "POOR SLEEP, SEDENTARY BEHAVIOR, AND SECONDARY CARDIOVASCULAR RISK IN STROKE AND TIA PATIENTS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f6a3877-304a-f4ec-9bd4-082c57aa1297-C", "generated_internal_id": "ASST_NON_R01HL141494_7529"}, {"internal_id": 49759415, "Award ID": "R01HL140580", "Award Amount": 3446062.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-12", "CFDA Number": "93.837", "Description": "STRENGTHENING CIRCADIAN SIGNALS TO ENHANCE CARDIOMETABOLIC FUNCTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_R01HL140580_7529"}, {"internal_id": 49759414, "Award ID": "R01HL140577", "Award Amount": 2876203.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-14", "CFDA Number": "93.837", "Description": "CIRCADIAN MECHANISMS OF CARDIOVASCULAR RISK IN OBESITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_R01HL140577_7529"}, {"internal_id": 49759413, "Award ID": "R01HL140574", "Award Amount": 4161442.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-14", "CFDA Number": "93.837", "Description": "ROLE OF MEAL TIMING IN EFFICACY OF BARIATRIC SURGERY IN OBESE INDIVIDUALS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL140574_7529"}, {"internal_id": 67314045, "Award ID": "R01HL139716", "Award Amount": 3355320.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-13", "CFDA Number": "93.837", "Description": "EVALUATING NOVEL APPROACHES FOR ESTIMATING AWAKE AND SLEEP BLOOD PRESSURE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "385a79b6-b810-9612-774a-ef5d04895c34-C", "generated_internal_id": "ASST_NON_R01HL139716_7529"}, {"internal_id": 49759341, "Award ID": "R01HL138932", "Award Amount": 2382523.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-04", "CFDA Number": "93.837", "Description": "CHEMOGENETIC APPROACH TO TREAT OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_R01HL138932_7529"}, {"internal_id": 67579913, "Award ID": "R01HL138551", "Award Amount": 2443378.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-29", "CFDA Number": "93.837", "Description": "CIRCADIAN RHYTHMS AND INTERNAL DESYNCHRONIZATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f879ffdd-a594-a5e7-2f71-72b5613abc69-C", "generated_internal_id": "ASST_NON_R01HL138551_7529"}, {"internal_id": 49759210, "Award ID": "R01HL137192", "Award Amount": 3522867.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-07", "CFDA Number": "93.837", "Description": "ENVIRONMENTAL RISK FACTORS FOR PEDIATRIC SLEEP DISORDERED BREATHING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18397352-674d-5e14-840f-49a4315ed3ca-C", "generated_internal_id": "ASST_NON_R01HL137192_7529"}, {"internal_id": 49759174, "Award ID": "R01HL136752", "Award Amount": 3558757.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-18", "CFDA Number": "93.837", "Description": "CHILD SLEEP AS A MECHANISM AND MODERATOR IN THE DEVELOPMENT OF HEALTH DISPARITIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dff5ea13-87ef-1d23-7ba0-fbf570ef2475-C", "generated_internal_id": "ASST_NON_R01HL136752_7529"}, {"internal_id": 68167954, "Award ID": "R01HL136587", "Award Amount": 3673254.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-08-29", "CFDA Number": "93.837", "Description": "THE PENN STATE CHILD SLEEP COHORT: CARDIOMETABOLIC AND NEUROCOGNITIVE RISK IN YOUNG ADULTHOOD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "47ed9961-3300-5ed7-bb62-e5359d99eaf9-C", "generated_internal_id": "ASST_NON_R01HL136587_7529"}, {"internal_id": 65579482, "Award ID": "R01HL136310", "Award Amount": 4130710.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-04-08", "CFDA Number": "93.837", "Description": "PATTERNS OF SLEEP RESTRICTION AND RECOVERY: THE INFLAMMATORY RESOLUTION PATHWAYS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2a11a6dc-948e-2337-13cf-40ff24b2768a-C", "generated_internal_id": "ASST_NON_R01HL136310_7529"}, {"internal_id": 49759047, "Award ID": "R01HL135598", "Award Amount": 2953097.16, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-12-19", "CFDA Number": "93.837", "Description": "SLEEP AND BLOOD PRESSURE-RELATED ENDOTHELIAL ABNORMALITIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7d586cfa-95f6-0e31-3589-fbd59b788eda-C", "generated_internal_id": "ASST_NON_R01HL135598_7529"}, {"internal_id": 67314662, "Award ID": "R01HL135562", "Award Amount": 2873133.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-13", "CFDA Number": "93.837", "Description": "GABA AND GLUTAMATE CHANGES UNDERLYING ALTERED AUTONOMIC FUNCTION IN OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3231cda5-201a-6da0-de9e-e9810a848983-C", "generated_internal_id": "ASST_NON_R01HL135562_7529"}, {"internal_id": 49759033, "Award ID": "R01HL135483", "Award Amount": 4289061.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-01-15", "CFDA Number": "93.837", "Description": "LIPOLYSIS DURING SLEEP AND CARDIOMETABOLIC CONSEQUENCES OF SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_R01HL135483_7529"}, {"internal_id": 49758946, "Award ID": "R01HL134885", "Award Amount": 3041323.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-05-31", "CFDA Number": "93.837", "Description": "SLEEP APNEA AND HYPERTROPHIC CARDIOMYOPATHY - IMPLICATIONS FOR ARRHYTHMIA AND SUDDEN DEATH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "30ebe932-79d5-1659-51b4-a59d9be01dee-C", "generated_internal_id": "ASST_NON_R01HL134885_7529"}, {"internal_id": 49758942, "Award ID": "R01HL134856", "Award Amount": 3110624.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-01-01", "CFDA Number": "93.837", "Description": "SLEEP AND WELL-BEING IN HIGH RISK YOUTH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "be04d9d3-d584-2183-f93b-e5cb978627ac-C", "generated_internal_id": "ASST_NON_R01HL134856_7529"}, {"internal_id": 49758933, "Award ID": "R01HL134838", "Award Amount": 1981250.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-12-22", "CFDA Number": "93.837", "Description": "EXAMINING THE ROLE OF GUT DYSBIOSIS IN OBSTRUCTIVE SLEEP APNEA INDUCED HYPERTENSION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ddcd398f-5e59-e840-2368-a57b84efdc7d-C", "generated_internal_id": "ASST_NON_R01HL134838_7529"}, {"internal_id": 49758923, "Award ID": "R01HL134808", "Award Amount": 3924157.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-07-19", "CFDA Number": "93.837", "Description": "SLEEP ENHANCEMENT TO DECREASE BLOOD PRESSURE: A RANDOMIZED, CONTROLLED TRIAL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "30ebe932-79d5-1659-51b4-a59d9be01dee-C", "generated_internal_id": "ASST_NON_R01HL134808_7529"}, {"internal_id": 49758862, "Award ID": "R01HL134015", "Award Amount": 3151287.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-12", "CFDA Number": "93.837", "Description": "APPROACHES TO GENETIC HETEROGENEITY OF OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL134015_7529"}, {"internal_id": 49758847, "Award ID": "R01HL133847", "Award Amount": 1299000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-07-31", "CFDA Number": "93.837", "Description": "CHEMOGENETIC DISSECTION OF NORADRENERGIC SYSTEM AND SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "84c69770-7b20-b9e0-d502-4ceb449256bf-C", "generated_internal_id": "ASST_NON_R01HL133847_7529"}, {"internal_id": 49758829, "Award ID": "R01HL133684", "Award Amount": 6511270.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-25", "CFDA Number": "93.837", "Description": "WOMEN'S HEALTH INITIATIVE SLEEP HYPOXIA EFFECTS ON RESILIENCE (WHISPER)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "623a4232-bd5e-fb60-cf01-48cd08a5a593-C", "generated_internal_id": "ASST_NON_R01HL133684_7529"}, {"internal_id": 49758788, "Award ID": "R01HL133327", "Award Amount": 3116321.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-12", "CFDA Number": "93.837", "Description": "SLEEP AND PAIN IN SICKLE CELL DISEASE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_R01HL133327_7529"}, {"internal_id": 49758751, "Award ID": "R01HL133100", "Award Amount": 4854179.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-06-10", "CFDA Number": "93.837", "Description": "LEPTIN SIGNALING IN THE CAROTID BODY: MECHANISMS AND CONSEQUENCES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ee8636d0-3f78-fbb3-4346-eb49aabbb2b3-C", "generated_internal_id": "ASST_NON_R01HL133100_7529"}, {"internal_id": 49758670, "Award ID": "R01HL132556", "Award Amount": 3451542.81, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-04-18", "CFDA Number": "93.837", "Description": "CIRCADIAN LIPIDOMICS IN CONSTANT ROUTINE, FORCED DESYNCHRONY, AND NON-LAB SETTING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL132556_7529"}, {"internal_id": 49758634, "Award ID": "R01HL132274", "Award Amount": 2061377.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-05-01", "CFDA Number": "93.837", "Description": "LONG-TERM TRAJECTORIES OF SUBJECTIVELY- AND POLYSOMNOGRAPHICALLY-ASSESSED SLEEP PATTERNS AS PREDICTORS OF NEUROENDOCRINE DYSFUNCTION AND WEIGHT GAIN IN ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d345a8ea-b0ac-7e5d-b949-6507917f2140-C", "generated_internal_id": "ASST_NON_R01HL132274_7529"}, {"internal_id": 49758610, "Award ID": "R01HL132150", "Award Amount": 1184805.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-20", "CFDA Number": "93.233", "Description": "BIOMARKERS OF INSUFFICIENT SLEEP AND SLEEPINESS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7d586cfa-95f6-0e31-3589-fbd59b788eda-C", "generated_internal_id": "ASST_NON_R01HL132150_7529"}, {"internal_id": 49758517, "Award ID": "R01HL131587", "Award Amount": 1957302.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-20", "CFDA Number": "93.837", "Description": "IMPROVING ASTHMA CONTROL USING INTERNET-BASED COGNITIVE-BEHAVIORAL TREATMENT FOR INSOMNIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_R01HL131587_7529"}, {"internal_id": 49758495, "Award ID": "R01HL131458", "Award Amount": 2999864.1, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-01-14", "CFDA Number": "93.837", "Description": "HIV-1, INSUFFICIENT SLEEP AND VASCULAR ENDOTHELIAL DYSFUNCTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7d586cfa-95f6-0e31-3589-fbd59b788eda-C", "generated_internal_id": "ASST_NON_R01HL131458_7529"}, {"internal_id": 49758464, "Award ID": "R01HL130984", "Award Amount": 2508082.41, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-04-11", "CFDA Number": "93.837", "Description": "HL - EXOSOMES, BLOOD BRAIN BARRIER, AND COGNITIVE FUNCTION IN PEDIATRIC OSA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f261384c-3ac1-b344-de46-81708f87aa6a-C", "generated_internal_id": "ASST_NON_R01HL130984_7529"}, {"internal_id": 49758427, "Award ID": "R01HL130702", "Award Amount": 2586418.76, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-04", "CFDA Number": "93.310", "Description": "PREDICTORS OF DE NOVO DEVELOPMENT OF OBSTRUCTIVE SLEEP APNEA IN PREGNANCY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8c42360e-cd0f-f49d-f961-6ea333c13ac6-C", "generated_internal_id": "ASST_NON_R01HL130702_7529"}, {"internal_id": 49758414, "Award ID": "R01HL130559", "Award Amount": 3701146.34, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-29", "CFDA Number": "93.837", "Description": "STEPPED-CARE MANAGEMENT OF INSOMNIA CO-OCCURRING WITH SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bd309640-1653-5700-35d0-e048570cf82a-C", "generated_internal_id": "ASST_NON_R01HL130559_7529"}, {"internal_id": 49758413, "Award ID": "R01HL130552", "Award Amount": 1497650.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-12", "CFDA Number": "93.837", "Description": "SLEEP-DISORDERED BREATHING IN PATIENTS WITH C-SCI: MECHANISMS AND THERAPY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "57f1d8a4-43a0-9952-a047-67afb28d0b55-C", "generated_internal_id": "ASST_NON_R01HL130552_7529"}, {"internal_id": 49758393, "Award ID": "R01HL130468", "Award Amount": 4198176.44, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-05", "CFDA Number": "93.837", "Description": "A COMPUTATIONAL BIOMECHANICAL AIRWAY MODEL FOR OBESE CHILDREN AT RISK FOR OSAS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b390b1e7-2bd3-be04-2015-3916c222ebaf-C", "generated_internal_id": "ASST_NON_R01HL130468_7529"}, {"internal_id": 49758250, "Award ID": "R01HL129138", "Award Amount": 3626678.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-08-24", "CFDA Number": "93.837", "Description": "MECHANISMS GOVERNING THE ESTROGENIC MODULATION OF SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "23b1535c-77e8-dafd-4ece-46b518206e5d-C", "generated_internal_id": "ASST_NON_R01HL129138_7529"}, {"internal_id": 49758236, "Award ID": "R01HL128970", "Award Amount": 5425044.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-08-10", "CFDA Number": "93.837", "Description": "TREATMENT OF SLEEP APNEA BY TARGETING LEPTIN SIGNALING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ee8636d0-3f78-fbb3-4346-eb49aabbb2b3-C", "generated_internal_id": "ASST_NON_R01HL128970_7529"}, {"internal_id": 49758205, "Award ID": "R01HL128658", "Award Amount": 2617275.36, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-10", "CFDA Number": "93.837", "Description": "CLINICAL METHODS FOR DETERMINING THE SITE AND SEVERITY OF PHARYNGEAL COLLAPSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL128658_7529"}, {"internal_id": 49758186, "Award ID": "R01HL128538", "Award Amount": 3550930.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-05-13", "CFDA Number": "93.837", "Description": "INFLUENCE OF SLEEP REGULARITY ON CIRCADIAN RHYTHMS, LEARNING, PERFORMANCE, AND MOOD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL128538_7529"}, {"internal_id": 49758119, "Award ID": "R01HL128226", "Award Amount": 2892132.77, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-17", "CFDA Number": "93.837", "Description": "EFFECT OF LONG-TERM SLEEP RESTRICTION ON ENERGY BALANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f6a3877-304a-f4ec-9bd4-082c57aa1297-C", "generated_internal_id": "ASST_NON_R01HL128226_7529"}, {"internal_id": 49757941, "Award ID": "R01HL126770", "Award Amount": 3309054.11, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-03-31", "CFDA Number": "93.837", "Description": "STRESS, SLEEP, AND ARTERIAL STIFFNESS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1882697f-2df0-529a-ed60-116702c184a7-C", "generated_internal_id": "ASST_NON_R01HL126770_7529"}, {"internal_id": 49757925, "Award ID": "R01HL126700", "Award Amount": 2964072.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-12-13", "CFDA Number": "93.837", "Description": "SLEEP APNEA AFTER STROKE: IMPLICATIONS FOR SCREENING AND TREATMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_R01HL126700_7529"}, {"internal_id": 49757854, "Award ID": "R01HL125893", "Award Amount": 2705731.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-07-13", "CFDA Number": "93.233", "Description": "CIRCADIAN RHYTHMS AND CARDIOVASCULAR RISK", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_R01HL125893_7529"}, {"internal_id": 49757787, "Award ID": "R01HL125379", "Award Amount": 4183791.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-19", "CFDA Number": "93.233", "Description": "MECHANISMS UNDERLYING THE BLOOD PRESSURE LOWERING EFFECT OF SLEEP EXTENSION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2a11a6dc-948e-2337-13cf-40ff24b2768a-C", "generated_internal_id": "ASST_NON_R01HL125379_7529"}, {"internal_id": 49757736, "Award ID": "R01HL124576", "Award Amount": 1843459.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-09", "CFDA Number": "93.233", "Description": "SHIFT WORK SLEEP LOSS: LOCUS COERULEUS NEURON SENESCENCE AND DEGENERATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL124576_7529"}, {"internal_id": 49757715, "Award ID": "R01HL124211", "Award Amount": 2143312.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-08-08", "CFDA Number": "93.837", "Description": "HORMONAL MECHANISMS OF SLEEP RESTRICTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5c561522-ef19-011a-85ba-0ef6e9e9c878-C", "generated_internal_id": "ASST_NON_R01HL124211_7529"}, {"internal_id": 49757631, "Award ID": "R01HL123379", "Award Amount": 1533534.72, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-04-16", "CFDA Number": "93.837", "Description": "NOCTURNAL ROSTRAL FLUID SHIFTS IN STROKE PATIENTS WITH SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_R01HL123379_7529"}, {"internal_id": 49757621, "Award ID": "R01HL123331", "Award Amount": 2163126.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-12-18", "CFDA Number": "93.837", "Description": "METABOLIC REGULATION OF WAKEFULNESS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL123331_7529"}, {"internal_id": 49757569, "Award ID": "R01HL122754", "Award Amount": 1681065.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-11-20", "CFDA Number": "93.837", "Description": "NEUROMETABOLIC ASSESSMENT OF OBSTRUCTIVE SLEEP APNEA BY MRI", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL122754_7529"}, {"internal_id": 49757525, "Award ID": "R01HL122460", "Award Amount": 3335613.74, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-01-15", "CFDA Number": "93.837", "Description": "NEIGHBORHOOD CHANGE: IMPACT ON SLEEP AND OBESITY-RELATED HEALTH DISPARITIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c2e789dd-a647-f435-a418-0a918163d623-C", "generated_internal_id": "ASST_NON_R01HL122460_7529"}, {"internal_id": 49757512, "Award ID": "R01HL122390", "Award Amount": 1871071.99, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-01-13", "CFDA Number": "93.837", "Description": "BROWN ADIPOSE TISSUE AND SLEEP REGULATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "358711ab-dfdd-d789-9d79-6eaf11629381-C", "generated_internal_id": "ASST_NON_R01HL122390_7529"}, {"internal_id": 49757382, "Award ID": "R01HL120909", "Award Amount": 2474186.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-09", "CFDA Number": "93.837", "Description": "UTILITY OF NASAL STEROIDS FOR TREATMENT OF CHILDHOOD OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_R01HL120909_7529"}, {"internal_id": 49757376, "Award ID": "R01HL120879", "Award Amount": 1842824.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-08-28", "CFDA Number": "93.233", "Description": "SLEEP RESTRICTION AND THE ADOLESCENT DIET:  IMPACT AND MECHANISMS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8ad38bc-2827-1399-cd46-c5204062852b-C", "generated_internal_id": "ASST_NON_R01HL120879_7529"}, {"internal_id": 49757365, "Award ID": "R01HL120693", "Award Amount": 3245241.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-03-20", "CFDA Number": "93.837", "Description": "TAILORED TREATMENT TO ENHANCE RISK PERCEPTION IN SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bd309640-1653-5700-35d0-e048570cf82a-C", "generated_internal_id": "ASST_NON_R01HL120693_7529"}, {"internal_id": 49757354, "Award ID": "R01HL120354", "Award Amount": 3276091.37, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-05-16", "CFDA Number": "93.837", "Description": "SLEEP DISORDERED BREATHING, OBESITY, AND PREGNANCY STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2d1f74d3-d7be-49bb-6383-d0367e272233-C", "generated_internal_id": "ASST_NON_R01HL120354_7529"}, {"internal_id": 49757256, "Award ID": "R01HL119161", "Award Amount": 1541550.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-07-30", "CFDA Number": "93.233", "Description": "IMPACT OF SLEEP IN THE RESTORING INSULIN SECRETION (RISE) STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4bd68be-2bd0-4a42-0d20-0ad92720d93c-C", "generated_internal_id": "ASST_NON_R01HL119161_7529"}, {"internal_id": 49757219, "Award ID": "R01HL118624", "Award Amount": 2687491.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-06-13", "CFDA Number": "93.233", "Description": "SLEEP DISORDERED BREATHING IN NORMAL ELDERLY AND RISK FOR ALZHEIMERS DISEASE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c07787b9-15d4-d1eb-4f0c-2e0b30320bfb-C", "generated_internal_id": "ASST_NON_R01HL118624_7529"}, {"internal_id": 49757217, "Award ID": "R01HL118601", "Award Amount": 2579729.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-05-23", "CFDA Number": "93.233", "Description": "DEVELOPMENT OF COUNTERMEASURES AGAINST ADVERSE METABOLIC EFFECTS OF SHIFT WORK", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL118601_7529"}, {"internal_id": 49757135, "Award ID": "R01HL117995", "Award Amount": 3103830.61, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-08-14", "CFDA Number": "93.837", "Description": "EXAMINING SLEEP & SOCIAL RHYTHMS AS MECHANISMS FOR WEIGHT GAIN AFTER JOB LOSS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4f121097-1173-861e-ba01-a877858acd3d-C", "generated_internal_id": "ASST_NON_R01HL117995_7529"}, {"internal_id": 49757115, "Award ID": "R01HL117871", "Award Amount": 2107803.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-05-23", "CFDA Number": "93.233", "Description": "TASK POTASSIUM CHANNEL ANTAGONISTS TO TREAT OPIOID DEPRESSION OF BREATHING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1b850e96-1988-60df-d05c-e0d42a91fc63-C", "generated_internal_id": "ASST_NON_R01HL117871_7529"}, {"internal_id": 49756991, "Award ID": "R01HL116490", "Award Amount": 4549631.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-08-08", "CFDA Number": "93.837", "Description": "LONGITUDINAL MEASUREMENT OF THE CHANGING SLEEP NEED IN ADOLESCENCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1e2f11d9-030b-5288-d89f-1f6fd7f111f3-C", "generated_internal_id": "ASST_NON_R01HL116490_7529"}, {"internal_id": 49756802, "Award ID": "R01HL114529", "Award Amount": 1914101.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-08-23", "CFDA Number": "93.233", "Description": "MULTIDISCIPLINARY TREATMENT FOR OBSTRUCTIVE SLEEP APNEA AND INSOMNIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_R01HL114529_7529"}, {"internal_id": 49756760, "Award ID": "R01HL114024", "Award Amount": 2734662.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-06-29", "CFDA Number": "93.233", "Description": "INTERACTIONS BETWEEN OBESITY RISK AND INSUFFICIENT SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "30ebe932-79d5-1659-51b4-a59d9be01dee-C", "generated_internal_id": "ASST_NON_R01HL114024_7529"}, {"internal_id": 49756703, "Award ID": "R01HL113251", "Award Amount": 1351933.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-08-15", "CFDA Number": "93.233", "Description": "BRAIN AXONAL INJURY IN OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3231cda5-201a-6da0-de9e-e9810a848983-C", "generated_internal_id": "ASST_NON_R01HL113251_7529"}, {"internal_id": 49756630, "Award ID": "R01HL112756", "Award Amount": 3141416.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-08-29", "CFDA Number": "93.837", "Description": "TEEN SCHOOL-NIGHT SLEEP EXTENSION: AN INTERVENTION TARGETING THE CIRCADIAN SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3686b736-a954-3213-3e70-ff260e0ab96a-C", "generated_internal_id": "ASST_NON_R01HL112756_7529"}, {"internal_id": 49756590, "Award ID": "R01HL112085", "Award Amount": 1472006.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-02-15", "CFDA Number": "93.233", "Description": "EFFECTS OF SLEEP DEPRIVATION ON INFECTION INDUCED ORGAN FAILURE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c477975b-68db-c3dc-4a79-b95cb9f6ab3e-C", "generated_internal_id": "ASST_NON_R01HL112085_7529"}, {"internal_id": 49756579, "Award ID": "R01HL111802", "Award Amount": 2120411.0, "Award Type": null, "Base Obligation Date": "2012-08-15", "CFDA Number": "93.233", "Description": "EARLY LIFE ADVERSITY, SLEEP, AND CARDIOVASCULAR RISK IN BLACK AND WHITE MEN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_R01HL111802_7529"}, {"internal_id": 49756575, "Award ID": "R01HL111725", "Award Amount": 1672780.0, "Award Type": null, "Base Obligation Date": "2012-08-09", "CFDA Number": "93.233", "Description": "GENETIC APPROACHES TO SLEEP/WAKE AND RESPONSE TO SLEEP LOSS IN MICE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL111725_7529"}, {"internal_id": 49756570, "Award ID": "R01HL111695", "Award Amount": 4240120.07, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-06-30", "CFDA Number": "93.837", "Description": "THE BENEFIT OF NAPS ON COGNITIVE, EMOTIONAL AND MOTOR LEARNING IN PRESCHOOLERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f879ffdd-a594-a5e7-2f71-72b5613abc69-C", "generated_internal_id": "ASST_NON_R01HL111695_7529"}, {"internal_id": 49756447, "Award ID": "R01HL110350", "Award Amount": 4040278.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-11-25", "CFDA Number": "93.233", "Description": "OBSTRUCTIVE SLEEP APNEA INCREASES CARDIOVASCULAR RISK IN TYPE 2 DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2a11a6dc-948e-2337-13cf-40ff24b2768a-C", "generated_internal_id": "ASST_NON_R01HL110350_7529"}, {"internal_id": 49756436, "Award ID": "R01HL110068", "Award Amount": 2916976.0, "Award Type": null, "Base Obligation Date": "2012-05-24", "CFDA Number": "93.233", "Description": "SLEEP-DISORDERED BREATHING AND RISK FOR CVD AND STROKE IN THE JACKSON HEART STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38806202-b2e1-fa5b-5787-e80ab7888442-C", "generated_internal_id": "ASST_NON_R01HL110068_7529"}, {"internal_id": 49756407, "Award ID": "R01HL109525", "Award Amount": 2077432.0, "Award Type": null, "Base Obligation Date": "2011-07-13", "CFDA Number": "93.233", "Description": "GENETICS OF SLEEP IN ZEBRAFISH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3c727a6e-aeb7-b7bb-b622-36f566d604a5-C", "generated_internal_id": "ASST_NON_R01HL109525_7529"}, {"internal_id": 49756400, "Award ID": "R01HL109493", "Award Amount": 3679972.0, "Award Type": null, "Base Obligation Date": "2011-08-14", "CFDA Number": "93.233", "Description": "ELUCIDATION OF THE INFLUENCE OF SLEEP APNEA ON RISK OF ATRIAL FIBRILLATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "513dbccc-53a8-be65-9d72-68c77a4f8608-C", "generated_internal_id": "ASST_NON_R01HL109493_7529"}, {"internal_id": 49756304, "Award ID": "R01HL108441", "Award Amount": 1385812.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-07-29", "CFDA Number": "93.233", "Description": "ULTRASHORT (MSEC) LIGHT EXPOSURE AS A COUNTERMEASURE TO CIRCADIAN DESYNCHRONY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ac01697b-b884-dbec-12f8-2f029a7cc4bb-C", "generated_internal_id": "ASST_NON_R01HL108441_7529"}, {"internal_id": 49756167, "Award ID": "R01HL106843", "Award Amount": 1964242.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-05-07", "CFDA Number": "93.233", "Description": "REGULATION OF BLOOD PRESSURE CIRCADIAN RHYTHM BY VASCULAR SMOOTH MUSCLE BMAL1", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c477975b-68db-c3dc-4a79-b95cb9f6ab3e-C", "generated_internal_id": "ASST_NON_R01HL106843_7529"}, {"internal_id": 49756127, "Award ID": "R01HL106041", "Award Amount": 5350183.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-05-26", "CFDA Number": "93.837", "Description": "VASCULAR ENDOTHELIAL ACTIVATION IN SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f6a3877-304a-f4ec-9bd4-082c57aa1297-C", "generated_internal_id": "ASST_NON_R01HL106041_7529"}, {"internal_id": 49756119, "Award ID": "R01HL105999", "Award Amount": 3179822.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-11-25", "CFDA Number": "93.233", "Description": "SLEEP-DISORDERED BREATHING AND CPAP AFTER ADENOTONSILLECTOMY IN CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_R01HL105999_7529"}, {"internal_id": 49756063, "Award ID": "R01HL105546", "Award Amount": 1959435.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-06-21", "CFDA Number": "93.233", "Description": "PATHOGENESIS AND OUTCOMES OF SLEEP DISORDERED BREATHING IN COPD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_R01HL105546_7529"}, {"internal_id": 49756036, "Award ID": "R01HL105395", "Award Amount": 2024215.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-04-09", "CFDA Number": "93.233", "Description": "ADOLESCENT SLEEP DELAY: CIRCADIAN REGULATION AND PHASE SHIFTING WITH LIGHT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3686b736-a954-3213-3e70-ff260e0ab96a-C", "generated_internal_id": "ASST_NON_R01HL105395_7529"}, {"internal_id": 49755978, "Award ID": "R01HL104127", "Award Amount": 2553087.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-06-15", "CFDA Number": "93.837", "Description": "NEUROPHYSIOLOGY OF BREATHING BEHAVIOR IN MAMMALS STUDIED IN NEONATAL MICE IN VITR", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "621f1721-8a91-41ed-a2d3-fd636268e5c5-C", "generated_internal_id": "ASST_NON_R01HL104127_7529"}, {"internal_id": 49755970, "Award ID": "R01HL104101", "Award Amount": 4333284.27, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-07-15", "CFDA Number": "93.837", "Description": "GLIAL CHEMOSENSITIVITY: MOLECULAR MECHANISMS OF PH SENSING AND INTERACTIONS WITH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f7d4a874-2ab3-85f8-4c06-002c8728886d-C", "generated_internal_id": "ASST_NON_R01HL104101_7529"}, {"internal_id": 49755895, "Award ID": "R01HL103607", "Award Amount": 5358949.87, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-03-25", "CFDA Number": "93.837", "Description": "THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL103607_7529"}, {"internal_id": 49755869, "Award ID": "R01HL102758", "Award Amount": 5091291.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-03-06", "CFDA Number": "93.837", "Description": "DAILY REGULATION OF IONIC CURRENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "23b1535c-77e8-dafd-4ece-46b518206e5d-C", "generated_internal_id": "ASST_NON_R01HL102758_7529"}, {"internal_id": 49755835, "Award ID": "R01HL102321", "Award Amount": 5756964.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-03-18", "CFDA Number": "93.837", "Description": "A METHOD FOR MEASURING AND MODELING THE PHYSIOLOGIC TRAITS CAUSING SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R01HL102321_7529"}, {"internal_id": 49755745, "Award ID": "R01HL098621", "Award Amount": 1854881.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-06-19", "CFDA Number": "93.233", "Description": "UNOBTRUSIVE MEASUREMENT OF SLEEP DISORDERED BREATHING IN THE HOME", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_R01HL098621_7529"}, {"internal_id": 49755562, "Award ID": "R01HL096750", "Award Amount": 4946007.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-03-15", "CFDA Number": "93.233", "Description": "RECOVERY OF RESPIRATORY FUNCTION AFTER SPINAL CORD INJURY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "30ebe932-79d5-1659-51b4-a59d9be01dee-C", "generated_internal_id": "ASST_NON_R01HL096750_7529"}, {"internal_id": 49755466, "Award ID": "R01HL095799", "Award Amount": 3761113.0, "Award Type": null, "Base Obligation Date": "2011-08-15", "CFDA Number": "93.233", "Description": "CHRONIC MODERATE SLEEP RESTRICTION IN OLDER LONG AND OLDER AVERAGE SLEEPERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18ebe923-151d-7095-dfea-7767365ba71d-C", "generated_internal_id": "ASST_NON_R01HL095799_7529"}, {"internal_id": 49754060, "Award ID": "R01HL085188", "Award Amount": 3535064.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2008-09-15", "CFDA Number": "93.837", "Description": "SINGLE MOTOR UNIT GENIOGLOSSUS RECORDINGS TO UNDERSTAND SLEEP APNEA PATHOGENESIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_R01HL085188_7529"}, {"internal_id": 49752925, "Award ID": "R01HL071194", "Award Amount": 10352200.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-07-05", "CFDA Number": "93.233", "Description": "OUTCOMES OF SLEEP DISORDERS IN OLDER MEN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7e9ab48c-ed7b-1b28-d315-5376f2046c8e-C", "generated_internal_id": "ASST_NON_R01HL071194_7529"}, {"internal_id": 49752588, "Award ID": "R01HL065272", "Award Amount": 1365818.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-06-16", "CFDA Number": "93.233", "Description": "CHOLINERGIC PHENOTYPE IN MURINE MODELS OF SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7bb49047-7166-d4e3-8873-4218d87cf06c-C", "generated_internal_id": "ASST_NON_R01HL065272_7529"}, {"internal_id": 49752579, "Award ID": "R01HL065176", "Award Amount": 3539013.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-03-09", "CFDA Number": "93.837", "Description": "CARDIOVASCULAR DISEASE MECHANISMS IN SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "30ebe932-79d5-1659-51b4-a59d9be01dee-C", "generated_internal_id": "ASST_NON_R01HL065176_7529"}, {"internal_id": 49752330, "Award ID": "R01HL059658", "Award Amount": 6333577.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2009-07-15", "CFDA Number": "93.837", "Description": "NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a43aff3e-a570-0cb9-f0e5-3f0b2cc7d6e9-C", "generated_internal_id": "ASST_NON_R01HL059658_7529"}, {"internal_id": 49752054, "Award ID": "R01HL047600", "Award Amount": 3486798.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2007-12-12", "CFDA Number": "93.233", "Description": "PREMOTOR CONTROL OF UPPER AIRWAY AND REM SLEEP ATONIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_R01HL047600_7529"}, {"internal_id": 49705438, "Award ID": "R00HL119618", "Award Amount": 535528.0, "Award Type": null, "Base Obligation Date": "2015-08-27", "CFDA Number": "93.233", "Description": "INTEGRATION OF SLEEP/WAKE NETWORK MODELS ACROSS MULTIPLE TEMPORAL AND SPATIAL SCA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_R00HL119618_7529"}, {"internal_id": 98487387, "Award ID": "P01HL149630", "Award Amount": 10634393.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-06-19", "CFDA Number": "93.837", "Description": "MECHANISMS OF SLEEP AND SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2a11a6dc-948e-2337-13cf-40ff24b2768a-C", "generated_internal_id": "ASST_NON_P01HL149630_7529"}, {"internal_id": 79638720, "Award ID": "P01HL144454", "Award Amount": 12669690.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-04-12", "CFDA Number": "93.837", "Description": "INTEGRATIVE CONSEQUENCES OF INTERMITTENT HYPOXIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4bd68be-2bd0-4a42-0d20-0ad92720d93c-C", "generated_internal_id": "ASST_NON_P01HL144454_7529"}, {"internal_id": 49359361, "Award ID": "P01HL095491", "Award Amount": 25062209.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-02-05", "CFDA Number": "93.837", "Description": "MECHANISMS OF STATE SWITCHING IN SLEEP AND SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2a11a6dc-948e-2337-13cf-40ff24b2768a-C", "generated_internal_id": "ASST_NON_P01HL095491_7529"}, {"internal_id": 49359355, "Award ID": "P01HL094307", "Award Amount": 23656857.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2009-06-18", "CFDA Number": "93.837", "Description": "ENDOPHENOTYPES OF SLEEP APNEA AND ROLE OF OBESITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_P01HL094307_7529"}, {"internal_id": 49359337, "Award ID": "P01HL088052", "Award Amount": 18499253.31, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2008-09-09", "CFDA Number": "93.837", "Description": "NEUROHUMORAL ADAPTATIONS TO CHRONIC INTERMITTENT HYPOXIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c2dad418-5c95-0983-b787-d49413633e9c-C", "generated_internal_id": "ASST_NON_P01HL088052_7529"}, {"internal_id": 85588355, "Award ID": "K99HL147212", "Award Amount": 205669.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-05-30", "CFDA Number": "93.837", "Description": "DETERMINING THE IMPORTANCE OF TEMPORAL REGULATION OF THE BLOOD-BRAIN BARRIER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_K99HL147212_7529"}, {"internal_id": 83795572, "Award ID": "K99HL144822", "Award Amount": 310127.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-01", "CFDA Number": "93.837", "Description": "IMPROVING OUTCOMES IN PEDIATRIC OBSTRUCTIVE SLEEP APNEA WITH COMPUTATIONAL FLUID DYNAMICS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8ad38bc-2827-1399-cd46-c5204062852b-C", "generated_internal_id": "ASST_NON_K99HL144822_7529"}, {"internal_id": 67313526, "Award ID": "K24HL143055", "Award Amount": 507515.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-19", "CFDA Number": "93.837", "Description": "SLEEP HEALTH IN SPECIAL POPULATIONS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3231cda5-201a-6da0-de9e-e9810a848983-C", "generated_internal_id": "ASST_NON_K24HL143055_7529"}, {"internal_id": 65894701, "Award ID": "K24HL138632", "Award Amount": 597930.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-04-28", "CFDA Number": "93.837", "Description": "MENTORSHIP IN THE ENDOCRINOLOGY OF SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5c561522-ef19-011a-85ba-0ef6e9e9c878-C", "generated_internal_id": "ASST_NON_K24HL138632_7529"}, {"internal_id": 48918027, "Award ID": "K24HL136859", "Award Amount": 571700.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-06-16", "CFDA Number": "93.837", "Description": "MENTORING PATIENT-ORIENTED RESEARCH: SLEEP & HEALTH DURING & AFTER HOSPITAL STAY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4bd68be-2bd0-4a42-0d20-0ad92720d93c-C", "generated_internal_id": "ASST_NON_K24HL136859_7529"}, {"internal_id": 48918021, "Award ID": "K24HL132105", "Award Amount": 610995.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-05-20", "CFDA Number": "93.837", "Description": "ASSESSMENT OF UPPER AIRWAY MECHANICS USING NEWER ELECTROMYOGRAPHIC TECHNIQUES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_K24HL132105_7529"}, {"internal_id": 48918020, "Award ID": "K24HL132093", "Award Amount": 335827.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-06-06", "CFDA Number": "93.837", "Description": "MENTORING IN SLEEP RESEARCH AND SLEEP INTERVENTIONS IN HEART DISEASE, AND STROKE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1882697f-2df0-529a-ed60-116702c184a7-C", "generated_internal_id": "ASST_NON_K24HL132093_7529"}, {"internal_id": 48918015, "Award ID": "K24HL127307", "Award Amount": 581644.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-08-13", "CFDA Number": "93.837", "Description": "MENTORED PATIENT ORIENTED RESEARCH IN SLEEP AND METABOLIC DISEASE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_K24HL127307_7529"}, {"internal_id": 48918001, "Award ID": "K24HL109156", "Award Amount": 1006474.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2013-07-18", "CFDA Number": "93.837", "Description": "MENTORING RESEARCH IN THE PHYSIOLOGY OF SLEEP DISORDERED BREATHING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bace221f-a1f9-fa20-66e4-55984406cf48-C", "generated_internal_id": "ASST_NON_K24HL109156_7529"}, {"internal_id": 48917998, "Award ID": "K24HL105664", "Award Amount": 1779112.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2010-09-16", "CFDA Number": "93.837", "Description": "HUMAN CIRCADIAN  SLEEP  CARDIOVASCULAR AND NEUROBEHAVIORAL RESPONSES TO LIGHT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1b850e96-1988-60df-d05c-e0d42a91fc63-C", "generated_internal_id": "ASST_NON_K24HL105664_7529"}, {"internal_id": 110463850, "Award ID": "K23HL150299", "Award Amount": 618721.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-14", "CFDA Number": "93.837", "Description": "EVIDENCE-BASED DETECTION OF PEDIATRIC OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "adf5ba97-e9a1-374f-72a1-40502b70df1a-C", "generated_internal_id": "ASST_NON_K23HL150299_7529"}, {"internal_id": 110464035, "Award ID": "K23HL150229", "Award Amount": 665280.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-14", "CFDA Number": "93.837", "Description": "SLEEP MANAGEMENT AND RECOVERY AFTER TRAUMATIC BRAIN INJURY IN KIDS (SMART-KIDS): EVIDENCE FOR TARGETING SLEEP TO IMPROVE OUTCOMES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_K23HL150229_7529"}, {"internal_id": 95942910, "Award ID": "K23HL150217", "Award Amount": 661071.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-03-13", "CFDA Number": "93.837", "Description": "A LINK BETWEEN SLEEP-WAKE DISTURBANCES AND ENLARGED PERIVASCULAR SPACES IN YOUTH WITH TRAUMATIC BRAIN INJURY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_K23HL150217_7529"}, {"internal_id": 85588302, "Award ID": "K23HL141682", "Award Amount": 952839.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-04-16", "CFDA Number": "93.837", "Description": "NOCTURNAL HYPERTENSION AND SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5f6a3877-304a-f4ec-9bd4-082c57aa1297-C", "generated_internal_id": "ASST_NON_K23HL141682_7529"}, {"internal_id": 85588368, "Award ID": "K23HL141581", "Award Amount": 795886.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-06-14", "CFDA Number": "93.837", "Description": "CIRCADIAN AND ULTRADIAN CORTISOL RHYTHMS IN CHRONIC SLEEP CONTINUITY DISTURBANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "868c3cd8-2896-4496-6775-ad6a8c69c6d6-C", "generated_internal_id": "ASST_NON_K23HL141581_7529"}, {"internal_id": 48916918, "Award ID": "K23HL138166", "Award Amount": 755407.45, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-04", "CFDA Number": "93.837", "Description": "CLINICAL TRANSLATION OF PHENOTYPES OF SHIFT WORK DISORDER", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4397aef3-70da-b831-0f7a-71049f3e955b-C", "generated_internal_id": "ASST_NON_K23HL138166_7529"}, {"internal_id": 65280646, "Award ID": "K23HL138155", "Award Amount": 839160.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-03-26", "CFDA Number": "93.837", "Description": "SLEEP DISTURBANCES AND LONG-TERM OUTCOMES AFTER CRITICAL ILLNESS IN CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e050350a-3939-bf65-9585-238517e3ab1f-C", "generated_internal_id": "ASST_NON_K23HL138155_7529"}, {"internal_id": 66199308, "Award ID": "K23HL135346", "Award Amount": 537214.2, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-05-18", "CFDA Number": "93.837", "Description": "MECHANISMS OF OBSTRUCTIVE SLEEP APNEA SYNDROME IN INFANTS WITH MICROGNATHIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_K23HL135346_7529"}, {"internal_id": 48916822, "Award ID": "K23HL127132", "Award Amount": 940630.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-01-01", "CFDA Number": "93.837", "Description": "DEVELOPING A PREDICTIVE MODEL OF THE OUTCOMES OF ADENOTONSILLECTOMY FOR PEDIATRIC OBSTRUCTIVE SLEEP APNEA SYNDROME", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "27f21ab2-7b66-cad9-be60-5f435f28b02f-C", "generated_internal_id": "ASST_NON_K23HL127132_7529"}, {"internal_id": 48916808, "Award ID": "K23HL125939", "Award Amount": 1159446.36, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-07-24", "CFDA Number": "93.866", "Description": "ADHERENCE TO PAP TREATMENT: INFLUENCES OF CO-MORBID INSOMNIA AND OF RACE/ETHNICITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c07787b9-15d4-d1eb-4f0c-2e0b30320bfb-C", "generated_internal_id": "ASST_NON_K23HL125939_7529"}, {"internal_id": 48916807, "Award ID": "K23HL125923", "Award Amount": 546945.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-06-26", "CFDA Number": "93.233", "Description": "SLEEP APNEA AND STELEVATION MYOCARDIAL INFARCTION A MULTIDISCIPLINARY TRANSLATIONAL STUDY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bace221f-a1f9-fa20-66e4-55984406cf48-C", "generated_internal_id": "ASST_NON_K23HL125923_7529"}, {"internal_id": 48916806, "Award ID": "K23HL125748", "Award Amount": 924368.94, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-08-31", "CFDA Number": "93.837", "Description": "IDENTIFYING NOVEL BEHAVIORAL TARGETS FOR IMPROVING SLEEP: A SELF-REGULATION MODEL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "527dc5e1-a727-1176-3f89-8c897c34dd95-C", "generated_internal_id": "ASST_NON_K23HL125748_7529"}, {"internal_id": 48916789, "Award ID": "K23HL122461", "Award Amount": 810711.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-05-18", "CFDA Number": "93.233", "Description": "SLEEP-DISORDERED BREATHING AND PAP IN PERINATAL DEPRESSION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_K23HL122461_7529"}, {"internal_id": 48916765, "Award ID": "K23HL118414", "Award Amount": 882798.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-09", "CFDA Number": "93.837", "Description": "OBSTRUCTIVE SLEEP APNEA AND GLYCEMIC VARIABILITY IN TYPE 2 DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18e10ac5-0c9e-d0fa-8dbc-a56771e0703d-C", "generated_internal_id": "ASST_NON_K23HL118414_7529"}, {"internal_id": 48916714, "Award ID": "K23HL110216", "Award Amount": 813272.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-08-09", "CFDA Number": "93.233", "Description": "CARDIOVASCULAR AND METABOLIC RISK FACTORS ASSOCIATED WITH SHORT SLEEP DURATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4f121097-1173-861e-ba01-a877858acd3d-C", "generated_internal_id": "ASST_NON_K23HL110216_7529"}, {"internal_id": 83103896, "Award ID": "K08HL148551", "Award Amount": 817766.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-08-15", "CFDA Number": "93.837", "Description": "CIRCADIAN CLOCK DYSREGULATION IN A MODEL OF OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8ad38bc-2827-1399-cd46-c5204062852b-C", "generated_internal_id": "ASST_NON_K08HL148551_7529"}, {"internal_id": 80401288, "Award ID": "K08HL147377", "Award Amount": 847704.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-04-18", "CFDA Number": "93.837", "Description": "FIBRO-ADIPOGENIC REMODELING OF THE DIAPHRAGM IN OBESITY-ASSOCIATED RESPIRATORY DYSFUNCTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_K08HL147377_7529"}, {"internal_id": 85589968, "Award ID": "K08HL143140", "Award Amount": 887760.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-05-13", "CFDA Number": "93.837", "Description": "HYPOXIA, HIF-1, AND THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_K08HL143140_7529"}, {"internal_id": 48913464, "Award ID": "K08HL112961", "Award Amount": 716736.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-07-26", "CFDA Number": "93.233", "Description": "SLEEP AS A NOVEL PATHWAY LINKING CHRONIC PSYCHOLOGICAL STRESS AND INFLAMMATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bb8d1cd4-e0ae-6348-a07c-04df6a112768-C", "generated_internal_id": "ASST_NON_K08HL112961_7529"}, {"internal_id": 48913449, "Award ID": "K08HL109475", "Award Amount": 719721.0, "Award Type": null, "Base Obligation Date": "2012-06-12", "CFDA Number": "93.233", "Description": "MECHANISMS AND CONSEQUENCES OF INTERMITTENT HYPOXIA-INDUCED LIPOLYSIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_K08HL109475_7529"}, {"internal_id": 97469558, "Award ID": "K01HL151673", "Award Amount": 551428.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-05-15", "CFDA Number": "93.837", "Description": "SLEEP AND CIRCADIAN RHYTHMS IN ADOLESCENCE: EPIGENETIC PATHWAYS OF CARDIOMETABOLIC RISK", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_K01HL151673_7529"}, {"internal_id": 110464325, "Award ID": "K01HL149987", "Award Amount": 647544.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-21", "CFDA Number": "93.837", "Description": "DEVELOPING AN INTERVENTION TARGETING SLEEP DISTURBANCES AMONG MINORITY BEREAVED INDIVIDUALS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_K01HL149987_7529"}, {"internal_id": 110464837, "Award ID": "K01HL149775", "Award Amount": 619766.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-02-15", "CFDA Number": "93.837", "Description": "MY ESSENCE - MINDFULNESS TO REDUCE STRESS, IMPROVE SIEEP, AND REDUCE CARDIOVASCULAR RISK IN AFRICAN-AMERICANS WITH TYPE 2 DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "98f86457-cdff-6b3c-9ff8-3a4415183bf6-C", "generated_internal_id": "ASST_NON_K01HL149775_7529"}, {"internal_id": 110463727, "Award ID": "K01HL146993", "Award Amount": 605755.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-03-17", "CFDA Number": "93.837", "Description": "DEVELOPING, IMPLEMENTING, AND EVALUATING A MIXED-METHODS COMMUNITY-BASED PARTICIPATORY RESEARCH SLEEP INTERVENTION IN FAMILIES WITH K-1ST GRADE CHILDREN LIVING ON THE BLACKFEET INDIAN RESERVATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "afdb5528-e0ac-3206-584e-b3140fd75926-C", "generated_internal_id": "ASST_NON_K01HL146993_7529"}, {"internal_id": 85588440, "Award ID": "K01HL145128", "Award Amount": 753570.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-07-23", "CFDA Number": "93.837", "Description": "ADIPOSITY AND SLEEP-ASSOCIATED CARDIOMETABOLIC DISEASE RISK FACTORS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "147e841a-32d5-d2fa-ae13-c808e4a7e703-C", "generated_internal_id": "ASST_NON_K01HL145128_7529"}, {"internal_id": 85589164, "Award ID": "K01HL145099", "Award Amount": 722586.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-13", "CFDA Number": "93.837", "Description": "BIOMARKERS AND ALTERED METABOLIC PATHWAYS DURING SLEEP LOSS AND CIRCADIAN DISRUPTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "105d3de4-6fbf-6e42-7259-4c62267aa84f-C", "generated_internal_id": "ASST_NON_K01HL145099_7529"}, {"internal_id": 85589632, "Award ID": "K01HL144914", "Award Amount": 537312.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-07-13", "CFDA Number": "93.837", "Description": "ASSOCIATIONS OF SLEEP DURATION AND DYNAMICS WITH BIOMARKERS OF CARDIOMETABOLIC DISEASES; A MICRO-LONGITUDINAL APPROACH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_K01HL144914_7529"}, {"internal_id": 68171038, "Award ID": "K01HL143034", "Award Amount": 884864.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-08-20", "CFDA Number": "93.837", "Description": "ELUCIDATING INFLAMMATORY AND METABOLIC PATHWAYS IN OBSTRUCTIVE SLEEP APNEA DEVELOPMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_K01HL143034_7529"}, {"internal_id": 67833467, "Award ID": "K01HL140283", "Award Amount": 846450.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-08-17", "CFDA Number": "93.837", "Description": "MULTILEVEL ANTECEDENTS OF SLEEP IN LATINO YOUTH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80dea171-5e28-7ab0-907e-93f184ba21cf-C", "generated_internal_id": "ASST_NON_K01HL140283_7529"}, {"internal_id": 48910261, "Award ID": "K01HL138211", "Award Amount": 858834.97, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-07-17", "CFDA Number": "93.837", "Description": "A MIXED METHODS APPROACH FOR DEVELOPING CULTURALLY AND ECOLOGICALLY APPROPRIATE INTERVENTIONS FOR IMPROVING SLEEP HEALTH IN A COMMUNITY-BASED SAMPLE OF AFRICAN AMERICANS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_K01HL138211_7529"}, {"internal_id": 68565165, "Award ID": "K01HL136884", "Award Amount": 848480.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-03-04", "CFDA Number": "93.837", "Description": "GENETIC AND MOLECULAR BASIS OF CIRCADIAN RHYTHM DISORDERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_K01HL136884_7529"}, {"internal_id": 48910247, "Award ID": "K01HL135405", "Award Amount": 660939.53, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-14", "CFDA Number": "93.837", "Description": "WHOLE GENOMIC CHARACTERIZATION OF SLEEP APNEA TRAITS AND COMORBID DISORDERS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_K01HL135405_7529"}, {"internal_id": 48910221, "Award ID": "K01HL130719", "Award Amount": 766211.89, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-01-13", "CFDA Number": "93.837", "Description": "CEREBRAL BLOOD FLOW AND NEUROCOGNITION IN CHILDREN WITH OBSTRUCTIVE SLEEP APNEA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_K01HL130719_7529"}, {"internal_id": 48910209, "Award ID": "K01HL129087", "Award Amount": 895620.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-08-15", "CFDA Number": "93.837", "Description": "SLEEP DURATION AND RISK FOR OBESITY IN MEXICAN AMERICAN CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bb8d1cd4-e0ae-6348-a07c-04df6a112768-C", "generated_internal_id": "ASST_NON_K01HL129087_7529"}, {"internal_id": 48910186, "Award ID": "K01HL123612", "Award Amount": 787334.13, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-07-20", "CFDA Number": "93.837", "Description": "SLEEP, ENERGETIC BEHAVIORS, AND ADOLESCENT OBESITY DURING THE TRANSITION FROM MIDDLE TO HIGH SCHOOL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b655b3eb-6e27-dfdd-c16c-ad7f8949f987-C", "generated_internal_id": "ASST_NON_K01HL123612_7529"}, {"internal_id": 110464954, "Award ID": "F32HL154792", "Award Amount": 52316.98, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-02", "CFDA Number": "93.837", "Description": "NEUROPEPTIDE CORTISTATIN: A POTENTIAL NEOCORTICAL REGULATOR OF SLEEP HOMEOSTASIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0c13d643-4334-38ed-1952-0db7e2ac5e56-C", "generated_internal_id": "ASST_NON_F32HL154792_7529"}, {"internal_id": 109278446, "Award ID": "F32HL154530", "Award Amount": 134416.12, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-19", "CFDA Number": "93.837", "Description": "THE LONGITUDINAL INFLUENCE OF HOME DISORGANIZATION ON CHILDREN'S SLEEP VARIABILITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "873ae72b-bace-b481-a973-8304b7346bc0-C", "generated_internal_id": "ASST_NON_F32HL154530_7529"}, {"internal_id": 98486809, "Award ID": "F32HL151251", "Award Amount": 64052.76, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-06-25", "CFDA Number": "93.837", "Description": "MOTOR NEURON ADAPTATIONS TO SATISFY DIVERSE BEHAVIORAL DEMANDS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_F32HL151251_7529"}, {"internal_id": 97468498, "Award ID": "F32HL151168", "Award Amount": 203618.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-05-06", "CFDA Number": "93.837", "Description": "NOT ALL THOSE WHO WANDER ARE LOST:  SPECIFICATION OF LUNG INNERVATING SENSORY NEURONS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_F32HL151168_7529"}, {"internal_id": 98487273, "Award ID": "F32HL149458", "Award Amount": 65310.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-06-30", "CFDA Number": "93.837", "Description": "EXAMINING THE OPPOSING ROLES OF GENETICALLY DISTINCT VAGAL AFFERENTS IN SLEEP AND WAKEFULNESS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0c13d643-4334-38ed-1952-0db7e2ac5e56-C", "generated_internal_id": "ASST_NON_F32HL149458_7529"}, {"internal_id": 78598294, "Award ID": "F32HL143978", "Award Amount": 159446.86, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-03-01", "CFDA Number": "93.837", "Description": "COUPLING OF MUSCLE BLIND-DEPENDENT RNA PROCESSING TO THE CIRCADIAN CLOCK IN NEURONAL HOMEOSTASIS AND SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_F32HL143978_7529"}, {"internal_id": 67314476, "Award ID": "F32HL143893", "Award Amount": 141464.26, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-07-11", "CFDA Number": "93.837", "Description": "SLEEP AND CIRCADIAN EFFECTS ON MEMORY IN HEALTHY YOUNG AND OLDER ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9bfcd9fa-8c45-c6a1-1dd3-d2f18b527530-C", "generated_internal_id": "ASST_NON_F32HL143893_7529"}, {"internal_id": 48621546, "Award ID": "F32HL137227", "Award Amount": 62905.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-04-28", "CFDA Number": "93.233", "Description": "EXAMINING THE BI-DIRECTIONAL RELATIONSHIP BETWEEN SLEEP AND STRESS: A VICIOUS CYCLE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_F32HL137227_7529"}, {"internal_id": 48621522, "Award ID": "F32HL136004", "Award Amount": 68240.86, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-04-27", "CFDA Number": "93.837", "Description": "THE ASSOCIATION BETWEEN OBSTRUCTIVE SLEEP APNEA AND CANCER IN VA PATIENTS.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8a022699-f7be-356a-f01a-3aa6f76016ef-C", "generated_internal_id": "ASST_NON_F32HL136004_7529"}, {"internal_id": 48621501, "Award ID": "F32HL133772", "Award Amount": 172534.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-06-15", "CFDA Number": "93.233", "Description": "HYPOCRETINERGIC INTEGRATION OF CIRCADIAN RHYTHMS AND SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e0af38c9-92a8-f2cb-a5b8-4b4f14f99689-C", "generated_internal_id": "ASST_NON_F32HL133772_7529"}, {"internal_id": 109189749, "Award ID": "F31HL154855", "Award Amount": 125760.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-15", "CFDA Number": "93.837", "Description": "A MEDULLARY CIRCUIT CONTROLLING REM SLEEP", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_F31HL154855_7529"}, {"internal_id": 109189982, "Award ID": "F31HL154716", "Award Amount": 61714.81, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-15", "CFDA Number": "93.837", "Description": "PRENATAL SLEEP HEALTH, CORTISOL, AND GESTATIONAL WEIGHT GAIN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "56e7333e-38ec-5402-80b8-4d50309afb4c-C", "generated_internal_id": "ASST_NON_F31HL154716_7529"}, {"internal_id": 110463766, "Award ID": "F31HL151232", "Award Amount": 91945.4, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-12-15", "CFDA Number": "93.837", "Description": "EXAMINING THE LONG-TERM RELATIONSHIP BETWEEN SLEEP AND DIET", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce600306-35f6-a322-8af6-77e17ec30fe9-C", "generated_internal_id": "ASST_NON_F31HL151232_7529"}, {"internal_id": 109278504, "Award ID": "F31HL151126", "Award Amount": 34832.38, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-08-19", "CFDA Number": "93.837", "Description": "LIFE COURSE APPROACH TO RACIAL DISPARITIES IN SLEEP AND IMPLICATIONS ON CARDIOMETABOLIC RISK DURING ADULTHOOD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d4ce585-e95e-2593-758c-86dc120820ad-C", "generated_internal_id": "ASST_NON_F31HL151126_7529"}, {"internal_id": 78599032, "Award ID": "F31HL145831", "Award Amount": 72091.82, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-02-16", "CFDA Number": "93.837", "Description": "A NEW METHOD OF SPINAL STIMULATION TO ACTIVATE THE DIAPHRAGM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_F31HL145831_7529"}, {"internal_id": 61612005, "Award ID": "F31HL140822", "Award Amount": 48010.84, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-01-31", "CFDA Number": "93.837", "Description": "INNOVATIONS IN GENOME WIDE ASSOCIATION TESTING INSPIRED BY OBSTRUCTIVE SLEEP APNEA PHENOTYPES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f5f39b56-5a70-1fe5-798f-b53ffca1e353-C", "generated_internal_id": "ASST_NON_F31HL140822_7529"}, {"internal_id": 48613800, "Award ID": "F31HL137346", "Award Amount": 83895.37, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-04-26", "CFDA Number": "93.837", "Description": "SLEEP VARIABILITY, DIET, AND OBESITY RISK IN CHILDREN", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "56e7333e-38ec-5402-80b8-4d50309afb4c-C", "generated_internal_id": "ASST_NON_F31HL137346_7529"}, {"internal_id": 48613768, "Award ID": "F31HL136067", "Award Amount": 44505.88, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-01-26", "CFDA Number": "93.837", "Description": "THE ROLE OF CENTRAL 5-HT IN HEART RATE AND BLOOD PRESSURE REGULATION DURING SLEEP IN THE NEONATAL PERIOD", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f261384c-3ac1-b344-de46-81708f87aa6a-C", "generated_internal_id": "ASST_NON_F31HL136067_7529"}, {"internal_id": 48613667, "Award ID": "F31HL129633", "Award Amount": 107694.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-09-01", "CFDA Number": "93.233", "Description": "MOLECULAR MECHANISMS AND NEURAL CIRCUITRY THAT REGULATE SLEEP HOMEOSTASIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ce42d274-7283-659b-de1c-e11666794c48-C", "generated_internal_id": "ASST_NON_F31HL129633_7529"}, {"internal_id": 48613658, "Award ID": "F31HL128124", "Award Amount": 90676.26, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-05-07", "CFDA Number": "93.837", "Description": "DEFINING MECHANISMS THAT REGULATE DIET-INDUCED WAKE IMPAIRMENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "75401b4c-967a-1918-9977-217d3ef9ce68-C", "generated_internal_id": "ASST_NON_F31HL128124_7529"}, {"internal_id": 77190450, "Award ID": "F30HL145901", "Award Amount": 177024.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-02-01", "CFDA Number": "93.837", "Description": "MECHANISMS OF ESTROGENIC MODULATION OF ADENOSINERGIC SLEEP PRESSURE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "23b1535c-77e8-dafd-4ece-46b518206e5d-C", "generated_internal_id": "ASST_NON_F30HL145901_7529"}]